{"gene":"GAB1","run_date":"2026-06-09T23:54:44","timeline":{"discoveries":[{"year":1996,"finding":"GAB1 interacts directly with the c-Met receptor tyrosine kinase via a proline-rich Met-binding domain (not related to known phosphotyrosine-binding domains); this interaction is specific to c-Met among tested tyrosine kinases. Expression of GAB1 in epithelial cells is sufficient to induce c-Met-specific branching morphogenesis.","method":"Co-immunoprecipitation, domain mapping, cell-based morphogenesis assay","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal binding experiments, domain mapping, functional rescue in epithelial cells; independently replicated in multiple subsequent studies","pmids":["8906793"],"is_preprint":false},{"year":1997,"finding":"Association of GAB1 with the Met/HGF receptor requires a functional Grb2 binding site at tyrosine 1356 (and to a lesser extent Y1349) in the receptor C-terminus; Met receptor mutants impaired in Grb2/GAB1 recruitment fail to induce branching tubulogenesis. GAB1 is the major substrate for the Met kinase in vitro and in vivo.","method":"In vitro kinase assay, co-immunoprecipitation with receptor mutants, tubulogenesis assay in MDCK cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro kinase substrate identification, receptor point mutant analysis, functional readout; replicated across labs","pmids":["9252406","9444958"],"is_preprint":false},{"year":1997,"finding":"GAB1 coupling to the Met receptor requires prior binding of Grb2 (both SH2 and SH3 domain-blocking peptides interfere with receptor–GAB1 interaction). GAB1 phosphorylation by Met correlates with the transforming potential of oncogenic Tpr-Met.","method":"Point mutations in Met docking site, SH2/SH3 blocking peptides, co-immunoprecipitation, transformation assay","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal approaches (peptide inhibition + mutational analysis + functional transformation assay), replicated by Nguyen et al. 1997","pmids":["9444958"],"is_preprint":false},{"year":1998,"finding":"GAB1 is tyrosine-phosphorylated in response to IL-6, IL-3, IFN-α, and IFN-γ. Upon IL-6/IL-3 stimulation, GAB1 forms a complex with PI3K and SHP-2. GAB1 overexpression enhances gp130-dependent ERK2 activation; this requires tyrosine 759 (the SHP-2 binding site of gp130) and involves PI3K and Ras.","method":"Co-immunoprecipitation, dominant-negative PI3K expression, wortmannin inhibition, ERK2 kinase assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (pharmacological inhibition + dominant-negative + mutational analysis), replicated in subsequent studies","pmids":["9632795"],"is_preprint":false},{"year":1998,"finding":"GAB1 is phosphorylated by the insulin receptor (IR) on tyrosine residues; Y472 is the major site for association with p85 (PI3K), with Y447 and Y589 also participating. Y627 is the primary site for SHP-2 SH2 domain binding. The GAB1 PH domain is not required for IR/GAB1 interaction in vitro but is crucial for tyrosine phosphorylation and SHP-2 association in intact cells.","method":"Modified yeast two-hybrid, in vitro phosphorylation/pull-down, site-directed mutagenesis","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — yeast two-hybrid + in vitro pull-down + mutagenesis, single lab but multiple orthogonal methods","pmids":["9658397"],"is_preprint":false},{"year":1999,"finding":"The GAB1 PH domain binds PtdIns(3,4,5)P3 specifically and mediates GAB1 translocation to the plasma membrane in response to EGF; this translocation is required for efficient GAB1 tyrosine phosphorylation. A positive feedback loop exists in which PI3K is both upstream (generating PtdIns(3,4,5)P3 to recruit GAB1 via PH domain) and downstream (activated by phospho-GAB1) effector. PTEN overexpression inhibits EGF signaling and GAB1 membrane translocation.","method":"PH domain–lipid binding assay (PtdIns specificity), membrane translocation by subcellular fractionation/imaging, dominant-interfering PI3K mutant, PTEN overexpression, mutant Gab1 rescue experiments","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (lipid binding, imaging, dominant-negative, PTEN, point mutants); replicated in subsequent studies","pmids":["10648629"],"is_preprint":false},{"year":1999,"finding":"The GAB1 PH domain is required for localization of GAB1 at sites of cell–cell contact and for PI3K-dependent epithelial tubulogenesis downstream from the Met receptor. PH-domain deletion causes cytoplasmic mislocalization. LY294002 (PI3K inhibitor) blocks GAB1 membrane localization.","method":"Confocal imaging of GFP-tagged GAB1 constructs, LY294002 treatment, tubulogenesis assay with rescue experiments","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct localization experiments, PI3K pharmacological inhibition, functional morphogenesis readout; replicated","pmids":["10022866"],"is_preprint":false},{"year":1999,"finding":"In response to EGF receptor (EGFR) stimulation, GAB1 associates with the EGFR in vivo and in vitro via phosphotyrosines 1068 and 1086 in the EGFR C-terminal tail. GAB1 overexpression potentiates EGF-induced MAPK and JNK activation in a manner requiring PI3K binding.","method":"Co-immunoprecipitation (in vivo and in vitro), receptor mutant analysis, PI3K dominant-interfering mutant, wortmannin treatment","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, receptor mapping by mutants, functional pathway activation; multiple orthogonal methods","pmids":["10648629"],"is_preprint":false},{"year":1999,"finding":"EGFR phosphorylates GAB1 at eight tyrosine residues in vitro (Y285, Y373, Y406, Y447, Y472, Y619, Y657, Y689); Y657 is the predominant phosphorylation site and a specific binding site for SHP-2/Syp, as shown by GST pull-down with Y657F mutant abrogating binding.","method":"In vitro EGFR kinase assay, phosphopeptide mapping by HPLC/Edman/MS, GST pull-down with cell lysates","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with purified EGFR kinase, mass spectrometry site identification, mutagenesis confirmation; single lab","pmids":["9890893"],"is_preprint":false},{"year":1999,"finding":"GAB1 associates with CRKL via the CRKL SH2 domain and GAB1 YXXP motifs after HGF stimulation; CRKL then engages C3G (via CRKL SH3 domain) to activate the small GTPase Rap1. A GabΔYXXP mutant abolishes HGF-induced Rap1 activation, identifying a HGF→GAB1→CRKL→C3G→Rap1 signaling pathway.","method":"Co-immunoprecipitation, dominant-negative C3G truncation, Rap1 activation assay, GAB1 YXXP mutant","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, dominant-negative epistasis, GTPase activation assay, mutant GAB1; single lab but multiple orthogonal methods","pmids":["10753869"],"is_preprint":false},{"year":1999,"finding":"GAB1 mediates NGF-independent neurite outgrowth, DNA synthesis, and cell survival in PC12 cells. Constitutively phosphorylated GAB1 induces Akt and MAPK activation; neuritogenesis is abolished by MEK inhibition and partially by PI3K inhibition; survival requires both PI3K and MEK pathways.","method":"Recombinant adenovirus-driven GAB1 expression, pharmacological inhibitors (MEK, PI3K), neurite outgrowth assay, MTT survival assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean loss/gain-of-function with specific phenotypic readouts, pathway inhibitors; single lab","pmids":["10601297"],"is_preprint":false},{"year":1999,"finding":"GAB1 is tyrosine-phosphorylated by erythropoietin (EPO) receptor activation and subsequently associates with PI3K (p85), SHP2, SHIP, and SHC; GAB1–Grb2 association increases upon EPO stimulation. GAB1 is the primary IRS-related protein activated by EPO in primary erythroid progenitors.","method":"Co-immunoprecipitation, EPO dose-response/time-course phosphorylation, primary cell analysis","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP panel of binding partners, primary cell validation; single lab, no epistasis","pmids":["10194437"],"is_preprint":false},{"year":2000,"finding":"The c-Met binding site on GAB1 is localized to a 13-amino acid region unique to GAB1; insertion of this region into Gab2 confers c-Met binding activity. Two Grb2 binding sites were mapped: a classical PXXP motif and a novel PX(V/I)(D/N)RXXKP motif. Association of GAB1 with SHP2 (not PI3K, CRKL, or Shc) is essential for HGF/Met-induced branching morphogenesis in MDCK cells.","method":"Reverse yeast two-hybrid technology, phosphorylation-dependent yeast two-hybrid, domain swapping (Gab2 chimera), MDCK branching morphogenesis assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — yeast two-hybrid domain mapping, chimeric protein rescue, functional morphogenesis assay; replicated by multiple labs","pmids":["10871282"],"is_preprint":false},{"year":2000,"finding":"GAB1-deficient embryos die in utero with defects in heart, placenta, and skin, and show severely reduced ERK MAPK activation in response to HGF, PDGF, EGF, and gp130 stimulation, establishing GAB1 as a common adapter for ERK activation by multiple growth factors and cytokines in vivo.","method":"Gab1 gene targeting (knockout mice), ERK activation assay in embryonic cells, phenotypic analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout with biochemical pathway readout and multiple ligand conditions; replicated","pmids":["10779359"],"is_preprint":false},{"year":2000,"finding":"Gab1 is essential for c-Met signaling in vivo: Gab1−/− mice phenocopy c-Met mutants in muscle progenitor migration defects (absent forelimb extensor muscles, diaphragm muscle loss), liver size reduction, and placental labyrinth defects. Gab1−/−;c-Met+/− compound mutants show enhanced muscle migration defects, providing genetic epistasis evidence that GAB1 is essential for c-Met signaling.","method":"Targeted mutagenesis in mouse, genetic epistasis (double mutant analysis), histological phenotypic analysis","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis in vivo, phenocopy of receptor mutant, compound mutant analysis; replicated","pmids":["10995442"],"is_preprint":false},{"year":2000,"finding":"CXCR4 and GAB1 interact genetically in migrating muscle progenitor development: muscle progenitors fail to reach the tongue anlage in CXCR4;Gab1 double mutants but colonize this target in either single mutant, demonstrating cooperative/synergistic genetic interaction.","method":"Double-mutant mouse analysis, genetic epistasis","journal":"Genes & development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic epistasis in vivo; single study","pmids":["16166380"],"is_preprint":false},{"year":2001,"finding":"Phosphotyrosines 627 and 659 of GAB1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) that binds SHP2 tandem SH2 domains in a specific orientation (N-SH2→pY627, C-SH2→pY659) and activates SHP2 phosphatase activity. GAB1 is also a substrate of SHP2 (dephosphorylated by SHP2 in vitro and confirmed by substrate-trapping in cells). Physical association of active SHP2 with GAB1 (not just SHP2 activity alone) is necessary and sufficient for ERK2 activation.","method":"Far Western blot (tandem SH2 orientation), in vitro SHP2 phosphatase assay with bisphosphopeptides, substrate-trapping with catalytically inactive SHP2, chimeric Gab1FF-SHP2ΔN rescue","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of SHP2 activation, far Western mapping, substrate-trapping, chimeric rescue; multiple orthogonal methods in single rigorous study","pmids":["11323411"],"is_preprint":false},{"year":2001,"finding":"Activated ERK2 directly associates with GAB1 via the Met-binding domain (MBD) exclusively in its phosphorylated form; GAB1 is an ERK2 substrate in vitro and shows increased serine phosphorylation in cells co-expressing constitutively active MEK1. ERK-mediated phosphorylation of GAB1 at a threonine adjacent to the pY472 site (pYT peptide) increases affinity for p85 PI3K, providing positive feedback (HGF context).","method":"GST pull-down with purified pERK2 vs non-pERK2, co-immunoprecipitation in intact cells, in vitro kinase assay, phosphopeptide competition/pull-down assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro reconstitution with purified kinase, co-IP in cells, peptide biochemistry; single lab, two orthogonal methods","pmids":["10593929","11445578"],"is_preprint":false},{"year":2001,"finding":"ERK negatively regulates GAB1 tyrosine phosphorylation and GAB1/PI3K interaction in the EGF (but not HGF) context: MEK inhibition by U0126 increases EGF-stimulated GAB1 tyrosine phosphorylation, SHP2 association, and GAB1/p85 association and PI3K/Akt activation. SHP2 dephosphorylates GAB1, suggesting EGF-stimulated ERK acts through SHP2 to reduce GAB1 phosphorylation.","method":"MEK inhibitor (U0126), co-immunoprecipitation, GST-p85 pull-down, pervanadate treatment, dominant-negative SHP2","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological and dominant-negative epistasis, Co-IP; single lab, multiple conditions","pmids":["11896055"],"is_preprint":false},{"year":2001,"finding":"PKC-α and PKC-β1 mediate serine/threonine hyperphosphorylation of GAB1 (upon PP1/PP2A inhibition by okadaic acid), which suppresses GAB1 tyrosine phosphorylation and its recruitment of PI3K, providing a negative-feedback mechanism for HGF/Met receptor signaling.","method":"Okadaic acid treatment, PKC isoform-specific inhibitors/activators, co-immunoprecipitation, phosphoamino acid analysis","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological dissection of kinase isoforms + biochemical readout; single lab","pmids":["11313945"],"is_preprint":false},{"year":2001,"finding":"ERK regulates the HGF-mediated GAB1/PI3K interaction positively: ERK inhibition reduces HGF-stimulated association of Gab1 with p85 and decreases Akt activation; a phosphothreonine+phosphotyrosine (pYT) peptide at the GAB1 YVPM motif shows higher affinity for p85 than phosphotyrosine alone, indicating ERK-phosphorylated threonine at T476 augments PI3K recruitment.","method":"MEK inhibitor, GST-p85 pull-down, co-immunoprecipitation, synthetic pY and pYT peptide competition assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro peptide biochemistry + cell Co-IP + pharmacological epistasis; single lab, orthogonal methods","pmids":["11445578"],"is_preprint":false},{"year":2001,"finding":"GAB1 forms complexes with p85 PI3K and SHP2 upon Met transformation; Crk associates with Gab1 (not p130Cas/paxillin) in Met-transformed cells and in suspension-grown cells, and Gab1-Crk coupling activates JNK in anchorage-independent conditions.","method":"Co-immunoprecipitation in adherent and suspension conditions, JNK activation assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP in multiple conditions, JNK readout; single lab","pmids":["11146548"],"is_preprint":false},{"year":2002,"finding":"GAB1 recruits SHP2 to dephosphorylate paxillin, causing dissociation of Csk from paxillin, which dephosphorylates Src Y530 and activates Src. This Gab1→SHP2→paxillin dephosphorylation→Src activation pathway is required for EGF-induced ERK activation and cell migration; SHP2-binding-defective Gab1FF blocks all these events.","method":"Co-immunoprecipitation, SHP2 substrate assay (paxillin dephosphorylation in vitro and in cells), Src Y530 phosphorylation analysis, cell migration assay, dominant-negative SHP2","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro phosphatase assay on paxillin + mutant Gab1 + dominant-negative SHP2 + migration readout; single lab, multiple orthogonal methods","pmids":["14665621"],"is_preprint":false},{"year":2002,"finding":"GAB1 and SHP2 promote Ras/MAPK activity in epidermis: Gab1-deficient epidermis shows lower active Ras and MAPK levels; Gab1Y627F (SHP2-binding-defective) reduces basal Ras and triggers differentiation; these effects are rescued by active Ras, placing GAB1/SHP2 upstream of Ras.","method":"Gab1−/− mouse epidermis, dominant-negative SHP2, Gab1Y627F mutant, activated Ras rescue, human epidermis organotypic culture","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout + epistasis (Ras rescue) + tissue-level functional readout; replicated","pmids":["12370245"],"is_preprint":false},{"year":2002,"finding":"IGF-1 downregulates GAB1 expression in endothelial cells; GAB1 associates with MEKK3 and inhibits MEKK3-induced c-Jun and NF-κB transcriptional activation; catalytically inactive MEKK3 also inhibits TNF-α-induced c-Jun and NF-κB activation, implicating the GAB1-MEKK3 complex in TNF-α signaling.","method":"Co-immunoprecipitation (Gab1-MEKK3), reporter assays (c-Jun, NF-κB), dominant-negative MEKK3, Western blot for Gab1 expression","journal":"Circulation research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP of novel interaction + reporter assay + dominant-negative epistasis; single lab","pmids":["12065326"],"is_preprint":false},{"year":2003,"finding":"Met-activated Gab1 directly interacts with cortactin via Gab1 proline-rich motifs P4/5 and the cortactin SH3 domain; this Gab1-cortactin complex is required for Met-mediated invadopodia formation and cell invasion. Uncoupling cortactin from Gab1 (via P4/5 mutations) abrogates invadopodia and invasion.","method":"Gab1-null fibroblasts, Gab1 siRNA in tumor cells, structure-function (P4/5 deletion mutants), direct interaction assay (cortactin SH3 pull-down), invadopodia assay, invasion assay","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Gab1-null cells + siRNA + domain mutants + direct interaction mapping + functional invasion readout; single lab, multiple orthogonal methods","pmids":["22366451"],"is_preprint":false},{"year":2003,"finding":"Grb2-independent recruitment of Gab1 to Met requires a 16-amino acid motif within the Gab1 Met-binding domain (MBD) and the structural integrity of the Met kinase domain C-terminal lobe including residues upstream of pY1349; substitution of Y1349 with an acidic residue (phosphomimetic) allows Gab1 MBD recruitment and Gab1 phosphorylation.","method":"Met kinase domain mutants, deletion mapping of Gab1 MBD (16-aa minimal motif), co-immunoprecipitation, in vitro binding","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain mapping, kinase mutants, binding assay; single lab","pmids":["12766170"],"is_preprint":false},{"year":2004,"finding":"ERK1/2 phosphorylates GAB1 at six serine/threonine residues (T312, S381, S454, T476, S581, S597) in vitro; S454, S581, S597, T476 account for ~80% of incorporated phosphate. These ERK phosphorylation sites are located adjacent to PI3K-binding YVPM motifs and their phosphorylation blocks PI3K and Akt activity in intact cells (insulin signaling context).","method":"In vitro ERK1/2 kinase assay, 2D-HPLC phosphopeptide mapping, MALDI-MS + Edman sequencing, PI3K/Akt activity assays in cells","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay + mass spectrometry site identification + functional PI3K/Akt readout in cells; single lab, multiple orthogonal methods","pmids":["15379552"],"is_preprint":false},{"year":2004,"finding":"EGF ligand binding increases EGFR kinase affinity (lowers Km ~4-6-fold) for Gab1 Y627 and Shc Y317 peptides while increasing kcat ~5-fold for all peptides, resulting in ~15–40-fold increase in specificity constants for these substrates vs ~5-fold for EGFR autophosphorylation sites. EGF significantly enhances Gab1 Y627 and Shc Y317 phosphorylation relative to EGFR autophosphorylation in cell lysates.","method":"Steady-state enzyme kinetics with synthetic peptides, purified EGFR, GST fusion protein binding assay, cell lysate phosphorylation comparison","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase kinetics with purified enzyme, multiple peptide substrates, cell lysate validation; single lab, rigorous biochemical study","pmids":["15231819"],"is_preprint":false},{"year":2004,"finding":"Noonan syndrome SHP2 mutants show increased basal phosphatase activity and prolonged, EGF-dependent binding to GAB1 with sustained tyrosine phosphorylation of both proteins. Coexpression of Gab1-FF (lacking SHP2 binding motifs) blocks EGF-mediated increase in SHP2 phosphatase activity and dramatically reduces ERK2 activation, demonstrating that docking through GAB1 is required for Noonan syndrome SHP2 mutant-driven sustained ERK2 activation.","method":"Phosphatase activity assay, co-immunoprecipitation time-course, Gab1-FF dominant-negative, ERK2 activation assay, cell proliferation assay","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 2 / Moderate — enzyme activity assay + Co-IP + dominant-negative epistasis + proliferation readout; single lab, multiple orthogonal methods","pmids":["14974085"],"is_preprint":false},{"year":2004,"finding":"GAB1 is the primary mediator of EGF-stimulated PI3K/Akt activation: Gab1−/− MEFs show severely impaired EGF-induced PI3K and Akt activation; three canonical GAB1 tyrosine phosphorylation sites mediate p85 complex formation. SHP2 association with GAB1 negatively regulates GAB1-mediated PI3K/Akt activation following EGFR stimulation.","method":"Gab1−/− MEFs, rescue with GAB1 mutants, PI3K assay, Akt phosphorylation, co-immunoprecipitation","journal":"BMC biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout plus mutant rescue with specific readouts; replicated","pmids":["15550174"],"is_preprint":false},{"year":2004,"finding":"SHP2 dephosphorylates YXXP motifs on GAB1 (including Y317-containing motif) to prevent RasGAP binding; when SHP2 is inactive, RasGAP binds phospho-Y317 on GAB1, relocates to the membrane, and inhibits Ras. A RasGAP-inactive mutant restores Ras activation in SHP2-deficient or Gab1-SHP2-binding-defective cells. GAB1 interacts with RasGAP SH2 domains via pY317.","method":"Substrate-trapping SHP2 mutant, Gab1 YXXP deletion mutant, RasGAP-inactive mutant rescue, RasGAP relocalization by fractionation, Ras activation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — substrate-trapping + deletion mutant + inactive mutant rescue + Ras activation readout; single lab, multiple orthogonal methods","pmids":["15574420"],"is_preprint":false},{"year":2005,"finding":"Laminar flow-induced GAB1 tyrosine phosphorylation is Src kinase-dependent and VEGFR2-dependent; phospho-GAB1 associates with p85 PI3K; a GAB1 mutant lacking p85 binding sites or Gab1 siRNA knockdown inhibits flow-induced Akt and eNOS activation.","method":"Src inhibitor PP2, VEGFR2 kinase inhibitors, co-immunoprecipitation, siRNA knockdown, Akt/eNOS phosphorylation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibitors + siRNA + mutant GAB1 + functional readouts; single lab","pmids":["15665327"],"is_preprint":false},{"year":2005,"finding":"Fluid shear stress-induced eNOS activation depends on GAB1-SHP2 interaction: mutation of GAB1 Y627F prevents shear-induced eNOS phosphorylation (but not Akt); dominant-negative SHP2 prevents PKA activation and eNOS phosphorylation. GAB1, SHP2, eNOS, and PKA catalytic subunit form a signalosome complex under shear. GAB1 PH domain is required for shear-induced Akt phosphorylation but not eNOS activation.","method":"GAB1 Y627F mutant, dominant-negative SHP2, co-immunoprecipitation of signalosome, PKA inhibitor, isolated murine carotid arteries (ex vivo validation)","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — co-immunoprecipitation of complex + multiple mutants + ex vivo vascular functional readout; single lab, multiple orthogonal methods","pmids":["16284184"],"is_preprint":false},{"year":2005,"finding":"Hck (hematopoietic cell kinase), a Src family kinase, phosphorylates GAB1 and GAB2 in response to IL-6 in multiple myeloma cells; PP2 (Src family inhibitor) and kinase-inactive Hck mutants reduce IL-6-triggered GAB1 tyrosine phosphorylation, ERK activation, and Akt activation, impairing myeloma cell proliferation and survival.","method":"Kinase-inactive Hck mutant expression, Src family kinase inhibitor PP2, co-immunoprecipitation, ERK/Akt assays, cell proliferation/survival assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinase-inactive mutant + pharmacological inhibitor + functional readouts; single lab","pmids":["15010462"],"is_preprint":false},{"year":2006,"finding":"GAB1 and SHP2 association is a critical event in liver regeneration: partial hepatectomy induces assembly of a Gab1-SHP2 complex in hepatocytes; liver-specific Gab1 knockout (LGKO) mice show defective ERK1/2 activation, decreased immediate-early gene expression, reduced cyclin levels, and suppressed hepatocyte proliferation after partial hepatectomy—phenocopying liver-specific Shp2 knockout mice.","method":"Liver-specific conditional Gab1 knockout, co-immunoprecipitation, ERK1/2 activation assay, gene expression analysis, BrdU proliferation assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout phenocopying Shp2 KO, co-IP, multiple downstream readouts; replicated","pmids":["16738330"],"is_preprint":false},{"year":2006,"finding":"GAB1 is required for VEGF-induced endothelial cell migration and capillary formation; GAB1 siRNA impairs PLCγ, ERK1/2, Src, and Akt activation by VEGF. GAB1 associates with VEGFR2, Grb2, PI3K, SHP2, Shc, and PLCγ in VEGF-stimulated cells; GAB1 mutants unable to bind SHP2 or PI3K mimic GAB1 depletion defects.","method":"siRNA knockdown, co-immunoprecipitation panel, overexpression of mutant GAB1, migration assay, tube formation assay, actin reorganization imaging","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — siRNA + mutant GAB1 + functional assays; single lab, multiple orthogonal methods","pmids":["17178724"],"is_preprint":false},{"year":2007,"finding":"Knockin mouse analysis demonstrates distinct in vivo requirements: PI3K recruitment by GAB1 is essential for EGFR-mediated eyelid closure and keratinocyte migration, while GAB1-SHP2 interaction is essential for Met-directed placental development and muscle progenitor limb migration. Either direct (via Met-binding domain) or indirect (via Grb2) GAB1 recruitment to Met is sufficient for muscle precursor migration, but both modes are required for placenta, liver growth, and palate development.","method":"Knockin mice with point mutations in PI3K, SHP2, Grb2, and Met-binding sites of Gab1; developmental phenotypic analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple in vivo knockin alleles with distinct phenotypic readouts; rigorous genetic epistasis study","pmids":["17881575"],"is_preprint":false},{"year":2008,"finding":"A new mechanism for Gab1 plasma membrane recruitment: ERK-dependent phosphorylation of Ser551 in Gab1 is required for its translocation to the plasma membrane; PI3K activity alone is insufficient. MAPK-dependent Ser551 phosphorylation represents a novel regulatory mode for PH domain function.","method":"ERK inhibitor, Ser551 phosphomutants, membrane fractionation/localization assay","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological ERK inhibition + phosphosite mutants + subcellular fractionation; single lab","pmids":["19050043"],"is_preprint":false},{"year":2009,"finding":"Pak4 is a novel Gab1-binding partner: Gab1 and Pak4 associate after HGF stimulation and colocalize at lamellipodia; the interaction requires Gab1 phosphorylation but not Pak4 kinase activity; it is mediated by a unique Gab1 region (no homology to known interaction motifs) and the GEF-interacting domain of Pak4. Gab1/Pak4 synergize in epithelial dispersal, migration, and invasion; a Pak4-binding-defective Gab1 mutant fails to promote these responses.","method":"Co-immunoprecipitation, colocalization imaging, Pak4 siRNA knockdown, Gab1 mutant lacking Pak4-binding region, migration/invasion assays, morphogenesis assay","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — novel interaction mapped + siRNA + mutant Gab1 + functional assays; single lab","pmids":["19289496"],"is_preprint":false},{"year":2009,"finding":"Crk SH2 domain mediates Gab1 interaction and recruits Src to phosphorylate Gab1 at Y307; this requires Src specifically (not Yes/Fyn). Gab1-Y307F mutant fails to localize near the plasma membrane upon HGF stimulation and reduces cell migration, focal adhesion formation, and localization of Crk, FAK, and paxillin.","method":"Crk/SH2 mutants, Src/Yes/Fyn triple-knockout fibroblasts, PP2 Src inhibitor, Y307F Gab1 mutant, focal adhesion imaging, cell migration assay","journal":"Cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic (triple KO fibroblasts) + pharmacological + mutant + functional readouts; single lab","pmids":["19350053"],"is_preprint":false},{"year":2010,"finding":"GAB1 scaffold is essential for dorsal ruffle formation downstream of Met, EGF, and PDGF receptors; GAB1 constitutively associates with N-WASP and recruits Nck into a dorsal-ruffle-localized complex upon RTK activation. Gab1ΔNck (Y407F) mutant fails to recruit Nck, prevents dorsal ruffles, decreases Met-dependent Rac activation, and impairs cell migration and epithelial remodeling.","method":"Gab1-null fibroblasts, co-immunoprecipitation (Gab1-N-WASP, Gab1-Nck), Gab1 Y407F mutant, dorsal ruffle quantification, Rac activation assay, migration assay","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — null cells + novel interaction (N-WASP, Nck) + mutant + Rac GTPase assay + functional readouts; single lab","pmids":["20332103"],"is_preprint":false},{"year":2011,"finding":"Endothelium-specific Gab1 knockout mice show impaired postnatal ischemic angiogenesis; HGF induces Gab1-SHP2 complex formation required for EC migration/proliferation via ERK1/2 and ERK5, and Gab1-p85 complex contributes to Akt activation and partial migration. HGF upregulates angiogenic genes (KLF2, Egr1) via Gab1-SHP2 complex.","method":"Endothelium-specific Gab1 KO mice, hindlimb ischemia model, co-immunoprecipitation, ERK1/2/5 assays, VEGF vs HGF gene transfer rescue, microarray","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO + in vivo ischemia model + gene transfer rescue + biochemical pathway mapping; multiple orthogonal methods","pmids":["21293003"],"is_preprint":false},{"year":2011,"finding":"Endothelium-specific Gab1 KO mice have impaired VEGF-induced eNOS activation and angiogenesis; Gab1/SHP2 association is required for PKA activation and eNOS phosphorylation; active PKA rescues VEGF-induced eNOS activation in EGKO ECs. Gab1/SHP2 interaction is required for tube formation in vitro and ischemic angiogenesis in vivo.","method":"Endothelium-specific Gab1 KO mice, Matrigel plug assay, co-IP, active PKA rescue, eNOS activation assay, tube formation assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO + active PKA rescue + multiple functional and biochemical readouts; replicated across labs","pmids":["21282639"],"is_preprint":false},{"year":2012,"finding":"GAB1 acts as a PAR protein scaffold: GAB1 directly interacts with PAR1 and PAR3; GAB1 binding enhances PAR1 kinase activity; GAB1 brings PAR1 and PAR3 into a transient complex promoting PAR3 phosphorylation by PAR1. GAB1 and PAR6 compete for PAR3 PDZ1 binding. GAB1 depletion causes PAR3 hypophosphorylation, increased PAR3/PAR6 complex, and accelerated tight junction formation. GAB1 overexpression disrupts apical-basal polarity and promotes multilumen cyst formation in a PAR1/PAR3-dependent manner.","method":"Co-immunoprecipitation, PAR1 kinase assay, domain competition assay (GAB1 vs PAR6 for PAR3 PDZ1), siRNA knockdown, overexpression, transepithelial resistance assay, 3D cyst morphogenesis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — kinase assay, domain binding competition, siRNA/OE with multiple functional readouts; single lab, multiple orthogonal methods","pmids":["22883624"],"is_preprint":false},{"year":2014,"finding":"Gαi1/3 are required for KGF (FGF-7) activation of PI3K-AKT-mTORC1 through GAB1: upon KGF stimulation, Gαi1/3 form a complex with KGFR and are required for subsequent GAB1 recruitment, phosphorylation, and PI3K-p85 activation. Gαi1/3 shRNA knockdown inhibits KGF-induced cell proliferation, migration, and cyclin D1/fibronectin accumulation.","method":"Co-immunoprecipitation (Gαi1/3-KGFR-GAB1 complex), shRNA knockdown, PI3K/Akt/mTOR activity assays, cell proliferation and migration assays","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP complex + shRNA + functional readouts; single lab","pmids":["25078664"],"is_preprint":false},{"year":2015,"finding":"EGF promotes SHP2 binding to tyrosine-phosphorylated GAB1, activating SHP2, which augments TGFβ-induced EMT. Knockdown of SHP2 and reconstitution with phosphotyrosine-binding-impaired SHP2 eliminates EGF-mediated EMT augmentation, demonstrating that physical SHP2 recruitment to GAB1 (not just SHP2 catalytic activity per se) is required.","method":"siRNA knockdown + SHP2 mutant rescue, co-immunoprecipitation, E-cadherin/vimentin expression, cell scatter assay","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA + domain-binding-dead mutant rescue + Co-IP + functional readouts; single lab","pmids":["26359300"],"is_preprint":false},{"year":2015,"finding":"EGFR-activated Src family kinases (SFKs) maintain GAB1 phosphorylation and GAB1-SHP2 complexes at a cytosolic site distal from EGFR; a delay in SFK inactivation after EGFR inactivation prolongs GAB1-SHP2 complex persistence beyond EGFR phosphorylation. This SFK-dependent mechanism is specific to EGFR and does not occur downstream of c-MET.","method":"Quantitative co-immunoprecipitation time-course, SFK inhibitors, computational modeling validated by experiment, EGFR vs c-MET comparison","journal":"Science signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative biochemical time-course + pharmacological + computational model validation; single lab","pmids":["25969544"],"is_preprint":false},{"year":2015,"finding":"Gab1 is required for normal hair cycle and hair follicle stem cell (HFSC) quiescence: conditional Gab1 knockout (K14-Cre or Krox20-Cre) prevents catagen entry; HFSCs lose quiescence and become exhausted. Conditional expression of gain-of-function Mek1(DD) (by Krox20-Cre) rescues hair cycle deficits and restores HFSC quiescence, placing GAB1 upstream of Shp2 and MAPK in this pathway.","method":"Conditional Gab1 knockout mice, Mek1(DD) gain-of-function knockin rescue, HFSC quantification, hair cycle analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO + gain-of-function genetic rescue with pathway placement; rigorous in vivo epistasis","pmids":["26456821"],"is_preprint":false},{"year":2016,"finding":"The non-receptor tyrosine kinase FER phosphorylates Met at Tyr1349 in an HGF-independent and Met autophosphorylation-independent manner; this promotes GAB1 recruitment and phosphorylation and activates the SHP2-ERK signaling pathway specifically (without activating Akt), thereby promoting ovarian cancer cell motility, invasion, and metastasis.","method":"FER siRNA/shRNA, phosphosite-specific antibodies, co-immunoprecipitation, kinase assay, cell migration/invasion, in vivo metastasis model","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — novel kinase identified with siRNA + in vivo model + biochemical pathway specificity; single lab, multiple orthogonal methods","pmids":["27401557"],"is_preprint":false},{"year":2018,"finding":"A p.Gly116Glu substitution in the GAB1 PH domain causes DFNB26 recessive profound deafness. METTL13 (dominant modifier DFNM1; p.Arg544Gln) coimmunoprecipitates with GAB1 and SPRY2, forming at least a tripartite complex; METTL13 modifier allele rescues GAB1 morphant phenotype in zebrafish. GAB1 p.Gly116Glu mutation dysregulates HGF, MET, SHP2, and SPRY2 expression; SPRY2 dysregulation is corrected in the presence of the METTL13 suppressor.","method":"Co-immunoprecipitation (METTL13-GAB1-SPRY2 complex), zebrafish morpholino rescue with human mRNA, gene expression profiling in human lymphoblastoid cells, human genetic mapping","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP of tripartite complex + zebrafish rescue + human cell expression analysis + genetic mapping; multiple orthogonal methods","pmids":["29408807"],"is_preprint":false},{"year":2020,"finding":"GAB1 is an essential effector of PDGF signaling in oligodendrocyte precursor cells (OPCs): conditional Gab1 deletion causes CNS hypomyelination by impairing OPC differentiation. GAB1 binds downstream to GSK3β and regulates its activity, thereby affecting β-catenin nuclear accumulation and expression of myelination-related transcription factors.","method":"Conditional Gab1 knockout in oligodendrocyte lineage, GSK3β binding (co-immunoprecipitation), β-catenin localization, transcription factor expression analysis, myelin staining","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO + novel binding partner (GSK3β) + downstream pathway readout; single lab, multiple orthogonal methods","pmids":["31944179"],"is_preprint":false}],"current_model":"GAB1 is a scaffold/docking protein that is recruited to multiple receptor tyrosine kinases (c-Met, EGFR, VEGFR2, PDGFR, RET, EpoR, gp130) via direct binding to the Met kinase domain through a unique 13-aa Met-binding domain (MBD) or indirectly through constitutive Grb2 association; upon receptor activation it is tyrosine-phosphorylated (by the receptor kinase or by Src family kinases such as Hck/Src/FER), and its phospho-YXXP motifs recruit SHP2 (via a bisphosphoryl BTAM at pY627/pY659), PI3K-p85 (via pY472/pY447), Crk/CRKL, RasGAP, cortactin, Nck, PAR1, and GSK3β; GAB1 acts as a positive feedback amplifier by using its PH domain to bind PI3K-generated PtdIns(3,4,5)P3 for membrane translocation, and it is negatively regulated by ERK-mediated serine/threonine phosphorylation (blocking PI3K binding), by SHP2-mediated dephosphorylation of its own tyrosines (including pY317 to disengage RasGAP and sustain Ras), and by PKC-mediated serine/threonine hyperphosphorylation; through these interactions GAB1 is essential for ERK/MAPK, PI3K/Akt, Src, Rac1/PAK, Rap1, and PKA/eNOS activation downstream of growth factors and cytokines, and in vivo is required for muscle progenitor migration, placental labyrinth development, liver regeneration, epithelial morphogenesis, hair follicle stem cell quiescence, CNS myelination, angiogenesis, and hearing (where a PH-domain p.Gly116Glu mutation causes DFNB26 deafness suppressed by a METTL13-GAB1-SPRY2 tripartite complex)."},"narrative":{"mechanistic_narrative":"GAB1 is a cytoplasmic scaffold/docking protein that couples diverse receptor tyrosine kinases and cytokine receptors to the ERK/MAPK and PI3K/Akt pathways, and is required in vivo for multiple growth-factor-dependent developmental and regenerative processes including muscle progenitor migration, placental and liver development, epithelial morphogenesis, angiogenesis, hair follicle stem cell quiescence, and CNS myelination [PMID:10779359, PMID:10995442, PMID:17881575, PMID:26456821, PMID:31944179]. It engages the c-Met receptor both directly, through a unique Met-binding domain whose 13-amino-acid core is sufficient to confer Met binding, and indirectly through constitutive Grb2 association at Met phosphotyrosine 1356 [PMID:8906793, PMID:9252406, PMID:9444958, PMID:10871282, PMID:12766170], while related recruitment to EGFR occurs via receptor phosphotyrosines 1068/1086 [PMID:10648629]. Upon receptor engagement GAB1 is tyrosine-phosphorylated by the receptor kinase or by Src-family kinases (Hck, Src) and the non-receptor kinase FER [PMID:9252406, PMID:9444958, PMID:15010462, PMID:19350053, PMID:27401557], generating docking sites that recruit SHP2 through a bisphosphoryl tyrosine-based activation motif at pY627/pY659 that orients and activates the SHP2 tandem SH2 domains, and that recruit PI3K-p85 through YVPM motifs [PMID:9890893, PMID:11323411, PMID:9658397, PMID:15550174]. GAB1-bound SHP2 drives Ras/ERK activation by dephosphorylating substrates such as paxillin (relieving Csk to activate Src) and by removing the RasGAP docking site at GAB1 pY317, thereby sustaining Ras [PMID:14665621, PMID:15574420, PMID:12370245]. GAB1 amplifies its own activation through a positive feedback loop in which its PH domain binds PI3K-generated PtdIns(3,4,5)P3 to translocate to the plasma membrane and to cell-cell contacts, a step required for efficient phosphorylation and morphogenesis [PMID:10648629, PMID:10022866]. GAB1 signaling is negatively regulated by ERK-mediated serine/threonine phosphorylation adjacent to PI3K-binding motifs and by PKC-mediated serine/threonine hyperphosphorylation, both of which suppress tyrosine phosphorylation and PI3K recruitment [PMID:15379552, PMID:11896055, PMID:11313945]. Beyond these core modules, GAB1 nucleates cytoskeletal and polarity complexes by recruiting cortactin, Nck/N-WASP, Pak4, and CRKL to drive invadopodia, dorsal ruffles, Rac and Rap1 activation, and cell migration [PMID:22366451, PMID:20332103, PMID:19289496, PMID:10753869], and acts as a scaffold organizing PAR1/PAR3 in epithelial polarity [PMID:22883624]. A GAB1 PH-domain p.Gly116Glu mutation causes DFNB26 recessive deafness, with a METTL13 modifier allele that forms a METTL13-GAB1-SPRY2 complex suppressing the phenotype [PMID:29408807].","teleology":[{"year":1996,"claim":"Established GAB1 as a direct c-Met-binding scaffold and showed it could drive a receptor-specific morphogenetic program, defining its role as a Met effector rather than a generic adapter.","evidence":"Co-immunoprecipitation, domain mapping, and branching morphogenesis assay in epithelial cells","pmids":["8906793"],"confidence":"High","gaps":["Did not resolve whether Met binding is direct in vivo versus Grb2-mediated","Downstream effectors not yet identified"]},{"year":1997,"claim":"Resolved the receptor-coupling architecture by showing GAB1 recruitment to Met requires the Grb2 binding site (Y1356) and that GAB1 is the principal Met kinase substrate, linking recruitment to function via tubulogenesis and transformation.","evidence":"In vitro kinase assay, receptor point mutants, MDCK tubulogenesis, SH2/SH3 blocking peptides, transformation assay","pmids":["9252406","9444958"],"confidence":"High","gaps":["Did not map GAB1 phosphosites or downstream binding partners","Direct vs Grb2-dependent contributions not separated"]},{"year":1998,"claim":"Generalized GAB1 beyond Met by showing tyrosine phosphorylation and SHP2/PI3K complex formation downstream of cytokine (gp130/IL-6, IL-3) and insulin receptors, and mapped the major PI3K (Y472) and SHP2 (Y627) docking tyrosines.","evidence":"Co-IP, dominant-negative PI3K, wortmannin, ERK assays, yeast two-hybrid and in vitro phosphorylation/mutagenesis","pmids":["9632795","9658397"],"confidence":"High","gaps":["Mechanism by which SHP2 promotes ERK not yet defined","Membrane recruitment mechanism unaddressed"]},{"year":1999,"claim":"Defined the PH-domain/PtdIns(3,4,5)P3 positive-feedback loop for membrane recruitment and extended GAB1 to EGFR, mapping additional phosphosites (Y657 for SHP2), and connected GAB1 to Rap1 (via CRKL/C3G) and to survival/differentiation outputs.","evidence":"PH-lipid binding, GFP imaging, PI3K dominant-negative, PTEN overexpression, EGFR mutant Co-IP, phosphopeptide mapping, CRKL/C3G epistasis, PC12 phenotypic assays","pmids":["10648629","10022866","9890893","10753869","10601297","10194437"],"confidence":"High","gaps":["Stoichiometry of the feedback loop not quantified","Relative contribution of each phosphosite in vivo unclear"]},{"year":2000,"claim":"Pinpointed the minimal 13-aa Met-binding determinant unique to GAB1 and demonstrated genetically that GAB1 is an obligate Met effector in vivo, with SHP2 (not PI3K/CRKL/Shc) coupling being essential for branching morphogenesis.","evidence":"Reverse/phosphorylation-dependent yeast two-hybrid, Gab2 domain-swap chimeras, Gab1 knockout mice with multi-ligand ERK assays and epistasis with c-Met","pmids":["10871282","10779359","10995442","16166380"],"confidence":"High","gaps":["Why SHP2 coupling is selectively essential not mechanistically explained at this stage","Tissue-specific effector requirements not yet dissected"]},{"year":2001,"claim":"Elucidated the SHP2 activation mechanism (pY627/pY659 bisphosphoryl BTAM activating the tandem SH2) and uncovered bidirectional ERK feedback plus PKC negative regulation, establishing GAB1 as a regulated signaling hub.","evidence":"Far Western SH2 orientation mapping, in vitro SHP2 phosphatase assays, substrate-trapping, chimeric rescue, MEK inhibitors, pYT peptide affinity assays, PKC isoform inhibitors","pmids":["11323411","10593929","11445578","11896055","11313945","11146548"],"confidence":"High","gaps":["Context-dependence of ERK feedback (HGF vs EGF) left partly unresolved","Phosphatase substrates of GAB1-bound SHP2 not yet identified"]},{"year":2002,"claim":"Identified the SHP2 substrate arm that drives ERK: GAB1-SHP2 dephosphorylates paxillin to activate Src, and demonstrated GAB1/SHP2 acts upstream of Ras/MAPK in epidermis with active Ras as a rescue.","evidence":"In vitro and cellular paxillin dephosphorylation, Src Y530 analysis, migration assays, Gab1-null epidermis with Gab1Y627F and activated Ras rescue, MEKK3 Co-IP/reporters","pmids":["14665621","12370245","12065326"],"confidence":"High","gaps":["Whether paxillin is the sole relevant SHP2 substrate unclear","MEKK3/NF-kB arm not connected to canonical ERK module"]},{"year":2004,"claim":"Defined the second SHP2 substrate mechanism — dephosphorylation of GAB1 pY317 to evict RasGAP and sustain Ras — and mapped the ERK-driven inhibitory serine/threonine sites adjacent to PI3K motifs, plus quantified EGFR substrate preference for GAB1.","evidence":"Substrate-trapping SHP2, RasGAP-inactive rescue, in vitro ERK kinase + MS phosphosite mapping, EGFR enzyme kinetics, Gab1-null MEFs, Noonan SHP2 mutant Co-IP","pmids":["15574420","15379552","15231819","15550174","14974085"],"confidence":"High","gaps":["In vivo importance of each ERK-target serine not tested individually","Integration of positive and negative ERK feedback not unified"]},{"year":2005,"claim":"Extended GAB1 to mechanotransduction and additional kinases, showing Src/VEGFR2-dependent GAB1 phosphorylation drives Akt/eNOS and that a GAB1-SHP2-eNOS-PKA signalosome controls eNOS, while Hck phosphorylates GAB1 in myeloma.","evidence":"Src/VEGFR2 inhibitors, siRNA, GAB1 mutants, signalosome Co-IP, ex vivo carotid arteries, PKA inhibitor, kinase-inactive Hck","pmids":["15665327","16284184","15010462"],"confidence":"Medium","gaps":["How PKA is activated within the signalosome not fully resolved","Tissue specificity of Hck vs Src usage unclear"]},{"year":2006,"claim":"Demonstrated physiological GAB1-SHP2 requirements in liver regeneration and VEGF-driven endothelial migration via conditional knockouts that phenocopy Shp2 loss.","evidence":"Liver-specific Gab1 knockout with partial hepatectomy, proliferation and gene expression readouts; VEGFR2 siRNA and mutant GAB1 in endothelial migration/tube assays","pmids":["16738330","17178724"],"confidence":"High","gaps":["Relative roles of SHP2 vs PI3K arms not separated in these tissues","Upstream receptor identity in regeneration not fully defined"]},{"year":2007,"claim":"Used knockin alleles to genetically separate GAB1 effector modules in vivo, showing PI3K coupling is required for EGFR-driven eyelid/keratinocyte functions while SHP2 coupling is required for Met-driven placenta and muscle migration.","evidence":"Knockin mice with point mutations in PI3K, SHP2, Grb2 and Met-binding sites; developmental phenotyping","pmids":["17881575"],"confidence":"High","gaps":["Molecular basis for why different tissues require different arms not explained","Redundancy with Gab2 not addressed"]},{"year":2008,"claim":"Revealed a PI3K-independent route to membrane recruitment via ERK-dependent Ser551 phosphorylation, refining the model of PH-domain regulation.","evidence":"ERK inhibitor, Ser551 phosphomutants, membrane fractionation","pmids":["19050043"],"confidence":"Medium","gaps":["How Ser551 phosphorylation alters PH-domain behavior is unresolved","Relative contribution vs PtdIns(3,4,5)P3 recruitment not quantified"]},{"year":2009,"claim":"Expanded GAB1's cytoskeletal/migration interactome by identifying Pak4 and Crk-recruited Src (phosphorylating GAB1 Y307) as drivers of lamellipodia, focal adhesion dynamics, and migration.","evidence":"Co-IP, colocalization, Pak4/Crk mutants, Src/Yes/Fyn triple-knockout fibroblasts, PP2, Gab1 point mutants, migration/invasion assays","pmids":["19289496","19350053"],"confidence":"Medium","gaps":["Structural basis of the Pak4-binding region undefined","In vivo relevance of Y307 not tested"]},{"year":2010,"claim":"Showed GAB1 nucleates a dorsal-ruffle actin module by constitutively binding N-WASP and recruiting Nck (via Y407) to activate Rac downstream of multiple RTKs.","evidence":"Gab1-null fibroblasts, Co-IP, Gab1 Y407F mutant, dorsal ruffle quantification, Rac activation and migration assays","pmids":["20332103"],"confidence":"Medium","gaps":["Quantitative link between Rac activation and morphogenesis incomplete","Single-lab characterization of the Nck/N-WASP module"]},{"year":2012,"claim":"Defined a non-canonical GAB1 role as a PAR-polarity scaffold that bridges PAR1 and PAR3 to control PAR3 phosphorylation, tight junction formation, and apical-basal polarity.","evidence":"Co-IP, PAR1 kinase assay, GAB1-vs-PAR6 PDZ1 competition, siRNA/overexpression, TER and 3D cyst morphogenesis assays","pmids":["22883624"],"confidence":"High","gaps":["Relationship between RTK signaling and the polarity scaffold function unclear","Whether tyrosine phosphorylation modulates PAR binding not defined"]},{"year":2015,"claim":"Broadened upstream inputs and outputs: Gαi1/3 are required for KGFR-to-GAB1 coupling, SFKs sustain spatially distal GAB1-SHP2 complexes selectively downstream of EGFR, SHP2 recruitment to GAB1 augments TGFβ-driven EMT, and GAB1 maintains hair follicle stem cell quiescence upstream of SHP2/MAPK.","evidence":"Co-IP, shRNA/siRNA, SFK inhibitors with computational modeling, SHP2 binding-dead rescue, conditional Gab1 knockout with Mek1(DD) rescue","pmids":["25078664","25969544","26359300","26456821"],"confidence":"High","gaps":["Mechanism of Gαi1/3-GAB1 coupling not structurally defined","Why SFK-sustained complexes are EGFR-specific not fully explained"]},{"year":2016,"claim":"Identified FER as an HGF-independent kinase that phosphorylates Met Y1349 to recruit GAB1 and selectively activate SHP2-ERK (not Akt), driving ovarian cancer invasion and metastasis.","evidence":"FER siRNA/shRNA, phosphosite antibodies, Co-IP, kinase assay, migration/invasion and in vivo metastasis models","pmids":["27401557"],"confidence":"High","gaps":["Basis for selective ERK (not Akt) activation by this route unexplained","Generalizability beyond ovarian cancer untested"]},{"year":2018,"claim":"Established a Mendelian disease link by showing a GAB1 PH-domain p.Gly116Glu mutation causes DFNB26 deafness, dysregulating HGF/MET/SHP2/SPRY2, with a METTL13 modifier forming a suppressive METTL13-GAB1-SPRY2 complex.","evidence":"Human genetic mapping, Co-IP of tripartite complex, zebrafish morpholino rescue, expression profiling in lymphoblastoid cells","pmids":["29408807"],"confidence":"High","gaps":["Biochemical effect of G116E on PtdIns(3,4,5)P3 binding not directly measured","Mechanism of METTL13 suppression not defined"]},{"year":2020,"claim":"Showed GAB1 is an essential PDGF effector in oligodendrocyte precursors that binds GSK3β to regulate β-catenin-dependent myelination transcription factors, linking GAB1 to CNS myelination.","evidence":"Conditional Gab1 knockout in oligodendrocyte lineage, GSK3β Co-IP, β-catenin localization, transcription factor analysis, myelin staining","pmids":["31944179"],"confidence":"High","gaps":["How GAB1 regulates GSK3β activity mechanistically not resolved","Whether GSK3β binding is direct or scaffold-mediated unclear"]},{"year":null,"claim":"How GAB1's many context-specific effector modules (SHP2, PI3K, RasGAP, CRKL, Nck/N-WASP, Pak4, GSK3β, PAR proteins) are spatially and temporally selected by different upstream receptors to produce distinct cellular outputs remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No integrated structural/biophysical model of how phosphosite usage is selected per receptor","Redundancy and division of labor between GAB1 and GAB2 not systematically mapped","Quantitative rules governing positive vs negative feedback balance unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,12,16,44]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[5,6]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[16,31]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[5,6,40]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[47,6]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[13,16,30]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[14,37,48,51]}],"complexes":["GAB1-SHP2 complex","GAB1-PI3K(p85) complex","GAB1-SHP2-eNOS-PKA signalosome","METTL13-GAB1-SPRY2 complex"],"partners":["MET","GRB2","PTPN11","PIK3R1","CRKL","SRC","CTTN","PAK4"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q13480","full_name":"GRB2-associated-binding protein 1","aliases":["GRB2-associated binder 1","Growth factor receptor bound protein 2-associated protein 1"],"length_aa":694,"mass_kda":76.6,"function":"Adapter protein that plays a role in intracellular signaling cascades triggered by activated receptor-type kinases. Plays a role in FGFR1 signaling. Probably involved in signaling by the epidermal growth factor receptor (EGFR) and the insulin receptor (INSR). Involved in the MET/HGF-signaling pathway (PubMed:29408807)","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/Q13480/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GAB1","classification":"Not Classified","n_dependent_lines":107,"n_total_lines":1208,"dependency_fraction":0.08857615894039735},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GAB1","total_profiled":1310},"omim":[{"mim_id":"617987","title":"METHYLTRANSFERASE 13, EEF1A LYSINE AND N-TERMINAL METHYLTRANSFERASE; METTL13","url":"https://www.omim.org/entry/617987"},{"mim_id":"610360","title":"MUCIN 20, CELL SURFACE-ASSOCIATED; MUC20","url":"https://www.omim.org/entry/610360"},{"mim_id":"609532","title":"HEPATITIS C VIRUS, SUSCEPTIBILITY TO","url":"https://www.omim.org/entry/609532"},{"mim_id":"606203","title":"GRB2-ASSOCIATED BINDING PROTEIN 2; GAB2","url":"https://www.omim.org/entry/606203"},{"mim_id":"605719","title":"LINKER FOR ACTIVATION OF T CELLS FAMILY, MEMBER 2; LAT2","url":"https://www.omim.org/entry/605719"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Nucleoli fibrillar center","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/GAB1"},"hgnc":{"alias_symbol":[],"prev_symbol":["DFNB26"]},"alphafold":{"accession":"Q13480","domains":[{"cath_id":"2.30.29.30","chopping":"6-20_27-123_550-559","consensus_level":"medium","plddt":81.1514,"start":6,"end":559}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13480","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13480-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13480-F1-predicted_aligned_error_v6.png","plddt_mean":52.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GAB1","jax_strain_url":"https://www.jax.org/strain/search?query=GAB1"},"sequence":{"accession":"Q13480","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13480.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13480/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13480"}},"corpus_meta":[{"pmid":"8906793","id":"PMC_8906793","title":"Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8906793","citation_count":501,"is_preprint":false},{"pmid":"10871282","id":"PMC_10871282","title":"Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses.","date":"2000","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10871282","citation_count":295,"is_preprint":false},{"pmid":"10648629","id":"PMC_10648629","title":"A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10648629","citation_count":291,"is_preprint":false},{"pmid":"9632795","id":"PMC_9632795","title":"Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9632795","citation_count":244,"is_preprint":false},{"pmid":"10779359","id":"PMC_10779359","title":"Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokine-induced extracellular signal-regulated kinase mitogen-activated protein kinase activation.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10779359","citation_count":224,"is_preprint":false},{"pmid":"10995442","id":"PMC_10995442","title":"Essential role of Gab1 for signaling by the c-Met receptor in vivo.","date":"2000","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10995442","citation_count":214,"is_preprint":false},{"pmid":"10022866","id":"PMC_10022866","title":"The Gab1 PH domain is required for localization of Gab1 at sites of cell-cell contact and epithelial morphogenesis downstream from the met receptor tyrosine kinase.","date":"1999","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10022866","citation_count":172,"is_preprint":false},{"pmid":"15574420","id":"PMC_15574420","title":"A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15574420","citation_count":167,"is_preprint":false},{"pmid":"12065326","id":"PMC_12065326","title":"Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression.","date":"2002","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/12065326","citation_count":159,"is_preprint":false},{"pmid":"14974085","id":"PMC_14974085","title":"Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.","date":"2004","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/14974085","citation_count":159,"is_preprint":false},{"pmid":"16166380","id":"PMC_16166380","title":"CXCR4 and Gab1 cooperate to control the development of migrating muscle progenitor cells.","date":"2005","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/16166380","citation_count":157,"is_preprint":false},{"pmid":"9252406","id":"PMC_9252406","title":"Association of the multisubstrate docking protein Gab1 with the hepatocyte growth factor receptor requires a functional Grb2 binding site involving tyrosine 1356.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9252406","citation_count":153,"is_preprint":false},{"pmid":"15550174","id":"PMC_15550174","title":"The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathway.","date":"2004","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/15550174","citation_count":152,"is_preprint":false},{"pmid":"14665621","id":"PMC_14665621","title":"Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14665621","citation_count":145,"is_preprint":false},{"pmid":"11323411","id":"PMC_11323411","title":"Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP2.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11323411","citation_count":145,"is_preprint":false},{"pmid":"32087725","id":"PMC_32087725","title":"LncRNA TUG1 alleviates sepsis-induced acute lung injury by targeting miR-34b-5p/GAB1.","date":"2020","source":"BMC pulmonary medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32087725","citation_count":139,"is_preprint":false},{"pmid":"24787006","id":"PMC_24787006","title":"miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24787006","citation_count":132,"is_preprint":false},{"pmid":"11896055","id":"PMC_11896055","title":"ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11896055","citation_count":122,"is_preprint":false},{"pmid":"9444958","id":"PMC_9444958","title":"Gab1 coupling to the HGF/Met receptor multifunctional docking site requires binding of Grb2 and correlates with the transforming potential.","date":"1997","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9444958","citation_count":116,"is_preprint":false},{"pmid":"10753869","id":"PMC_10753869","title":"Signaling of hepatocyte growth factor/scatter factor (HGF) to the small GTPase Rap1 via the large docking protein Gab1 and the adapter protein CRKL.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10753869","citation_count":116,"is_preprint":false},{"pmid":"25078664","id":"PMC_25078664","title":"Requirement of Gαi1/3-Gab1 signaling complex for keratinocyte growth factor-induced PI3K-AKT-mTORC1 activation.","date":"2014","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/25078664","citation_count":110,"is_preprint":false},{"pmid":"9242692","id":"PMC_9242692","title":"Efficient cellular transformation by the Met oncoprotein requires a functional Grb2 binding site and correlates with phosphorylation of the Grb2-associated proteins, Cbl and Gab1.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9242692","citation_count":104,"is_preprint":false},{"pmid":"11101839","id":"PMC_11101839","title":"Dominant modifier DFNM1 suppresses recessive deafness DFNB26.","date":"2000","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11101839","citation_count":101,"is_preprint":false},{"pmid":"10194437","id":"PMC_10194437","title":"Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10194437","citation_count":101,"is_preprint":false},{"pmid":"16738330","id":"PMC_16738330","title":"Concerted functions of Gab1 and Shp2 in liver regeneration and hepatoprotection.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16738330","citation_count":98,"is_preprint":false},{"pmid":"15665327","id":"PMC_15665327","title":"Flow shear stress stimulates Gab1 tyrosine phosphorylation to mediate protein kinase B and endothelial nitric-oxide synthase activation in endothelial cells.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15665327","citation_count":91,"is_preprint":false},{"pmid":"10455108","id":"PMC_10455108","title":"Engagement of Gab1 and Gab2 in erythropoietin signaling.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10455108","citation_count":84,"is_preprint":false},{"pmid":"16494942","id":"PMC_16494942","title":"Lenalidomide inhibits proliferation of Namalwa CSN.70 cells and interferes with Gab1 phosphorylation and adaptor protein complex assembly.","date":"2006","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/16494942","citation_count":83,"is_preprint":false},{"pmid":"17178724","id":"PMC_17178724","title":"The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17178724","citation_count":81,"is_preprint":false},{"pmid":"9804835","id":"PMC_9804835","title":"The Gab1 protein is a docking site for multiple proteins involved in signaling by the B cell antigen receptor.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9804835","citation_count":76,"is_preprint":false},{"pmid":"12370245","id":"PMC_12370245","title":"Gab1 and SHP-2 promote Ras/MAPK regulation of epidermal growth and differentiation.","date":"2002","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12370245","citation_count":75,"is_preprint":false},{"pmid":"16284184","id":"PMC_16284184","title":"Gab1, SHP2, and protein kinase A are crucial for the activation of the endothelial NO synthase by fluid shear stress.","date":"2005","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/16284184","citation_count":75,"is_preprint":false},{"pmid":"10618718","id":"PMC_10618718","title":"Met-induced JNK activation is mediated by the adapter protein Crk and correlates with the Gab1 - Crk signaling complex formation.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10618718","citation_count":74,"is_preprint":false},{"pmid":"10551845","id":"PMC_10551845","title":"An epidermal growth factor receptor/Gab1 signaling pathway is required for activation of phosphoinositide 3-kinase by lysophosphatidic acid.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10551845","citation_count":73,"is_preprint":false},{"pmid":"19289496","id":"PMC_19289496","title":"Pak4, a novel Gab1 binding partner, modulates cell migration and invasion by the Met receptor.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19289496","citation_count":69,"is_preprint":false},{"pmid":"25991585","id":"PMC_25991585","title":"MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression.","date":"2015","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25991585","citation_count":68,"is_preprint":false},{"pmid":"10601297","id":"PMC_10601297","title":"Gab1 mediates neurite outgrowth, DNA synthesis, and survival in PC12 cells.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10601297","citation_count":64,"is_preprint":false},{"pmid":"15952937","id":"PMC_15952937","title":"Participation of both Gab1 and Gab2 in the activation of the ERK/MAPK pathway by epidermal growth factor.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15952937","citation_count":64,"is_preprint":false},{"pmid":"11438654","id":"PMC_11438654","title":"The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11438654","citation_count":64,"is_preprint":false},{"pmid":"21282639","id":"PMC_21282639","title":"Grb-2-associated binder 1 (Gab1) regulates postnatal ischemic and VEGF-induced angiogenesis through the protein kinase A-endothelial NOS pathway.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21282639","citation_count":63,"is_preprint":false},{"pmid":"12629518","id":"PMC_12629518","title":"Gab1 is required for EGF receptor signaling and the transformation by activated ErbB2.","date":"2003","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12629518","citation_count":62,"is_preprint":false},{"pmid":"9658397","id":"PMC_9658397","title":"Determination of Gab1 (Grb2-associated binder-1) interaction with insulin receptor-signaling molecules.","date":"1998","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/9658397","citation_count":61,"is_preprint":false},{"pmid":"15010462","id":"PMC_15010462","title":"Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cells.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15010462","citation_count":59,"is_preprint":false},{"pmid":"22366451","id":"PMC_22366451","title":"Met receptor tyrosine kinase signals through a cortactin-Gab1 scaffold complex, to mediate invadopodia.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/22366451","citation_count":57,"is_preprint":false},{"pmid":"17881575","id":"PMC_17881575","title":"Distinct requirements for Gab1 in Met and EGF receptor signaling in vivo.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17881575","citation_count":54,"is_preprint":false},{"pmid":"26359300","id":"PMC_26359300","title":"EGF augments TGFβ-induced epithelial-mesenchymal transition by promoting SHP2 binding to GAB1.","date":"2015","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/26359300","citation_count":54,"is_preprint":false},{"pmid":"26456821","id":"PMC_26456821","title":"Gab1 and Mapk Signaling Are Essential in the Hair Cycle and Hair Follicle Stem Cell Quiescence.","date":"2015","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26456821","citation_count":53,"is_preprint":false},{"pmid":"11146548","id":"PMC_11146548","title":"A switch from p130Cas/Crk to Gab1/Crk signaling correlates with anchorage independent growth and JNK activation in cells transformed by the Met receptor oncoprotein.","date":"2000","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11146548","citation_count":52,"is_preprint":false},{"pmid":"12808090","id":"PMC_12808090","title":"Gab1 is an integrator of cell death versus cell survival signals in oxidative stress.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12808090","citation_count":51,"is_preprint":false},{"pmid":"25825741","id":"PMC_25825741","title":"Gαi1 and Gαi3 regulate macrophage polarization by forming a complex containing CD14 and Gab1.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25825741","citation_count":51,"is_preprint":false},{"pmid":"19050043","id":"PMC_19050043","title":"A new mechanism for the regulation of Gab1 recruitment to the plasma membrane.","date":"2008","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/19050043","citation_count":51,"is_preprint":false},{"pmid":"12058075","id":"PMC_12058075","title":"Distinct recruitment and function of Gab1 and Gab2 in Met receptor-mediated epithelial morphogenesis.","date":"2002","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12058075","citation_count":50,"is_preprint":false},{"pmid":"11278704","id":"PMC_11278704","title":"The Gab1 docking protein links the b cell antigen receptor to the phosphatidylinositol 3-kinase/Akt signaling pathway and to the SHP2 tyrosine phosphatase.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278704","citation_count":50,"is_preprint":false},{"pmid":"21293003","id":"PMC_21293003","title":"Docking protein Gab1 is an essential component of postnatal angiogenesis after ischemia via HGF/c-met signaling.","date":"2011","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/21293003","citation_count":49,"is_preprint":false},{"pmid":"11445578","id":"PMC_11445578","title":"ERK regulates the hepatocyte growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11445578","citation_count":48,"is_preprint":false},{"pmid":"16787925","id":"PMC_16787925","title":"The adaptor protein Gab1 couples the stimulation of vascular endothelial growth factor receptor-2 to the activation of phosphoinositide 3-kinase.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16787925","citation_count":48,"is_preprint":false},{"pmid":"18192688","id":"PMC_18192688","title":"Gab1 but not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells.","date":"2008","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/18192688","citation_count":48,"is_preprint":false},{"pmid":"12766170","id":"PMC_12766170","title":"Grb2-independent recruitment of Gab1 requires the C-terminal lobe and structural integrity of the Met receptor kinase domain.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12766170","citation_count":47,"is_preprint":false},{"pmid":"9890893","id":"PMC_9890893","title":"Identification of tyrosine phosphorylation sites in human Gab-1 protein by EGF receptor kinase in vitro.","date":"1999","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9890893","citation_count":47,"is_preprint":false},{"pmid":"15379552","id":"PMC_15379552","title":"Identification of major ERK-related phosphorylation sites in Gab1.","date":"2004","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15379552","citation_count":46,"is_preprint":false},{"pmid":"27401557","id":"PMC_27401557","title":"HGF-independent regulation of MET and GAB1 by nonreceptor tyrosine kinase FER potentiates metastasis in ovarian cancer.","date":"2016","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/27401557","citation_count":45,"is_preprint":false},{"pmid":"18025104","id":"PMC_18025104","title":"Signal strength dictates phosphoinositide 3-kinase contribution to Ras/extracellular signal-regulated kinase 1 and 2 activation via differential Gab1/Shp2 recruitment: consequences for resistance to epidermal growth factor receptor inhibition.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18025104","citation_count":44,"is_preprint":false},{"pmid":"26871477","id":"PMC_26871477","title":"MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26871477","citation_count":43,"is_preprint":false},{"pmid":"11707404","id":"PMC_11707404","title":"ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11707404","citation_count":43,"is_preprint":false},{"pmid":"15231819","id":"PMC_15231819","title":"Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15231819","citation_count":43,"is_preprint":false},{"pmid":"12819203","id":"PMC_12819203","title":"GC-GAP, a Rho family GTPase-activating protein that interacts with signaling adapters Gab1 and Gab2.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12819203","citation_count":42,"is_preprint":false},{"pmid":"11313945","id":"PMC_11313945","title":"Gab1 phosphorylation: a novel mechanism for negative regulation of HGF receptor signaling.","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11313945","citation_count":40,"is_preprint":false},{"pmid":"15849355","id":"PMC_15849355","title":"Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2.","date":"2005","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15849355","citation_count":40,"is_preprint":false},{"pmid":"15078886","id":"PMC_15078886","title":"ERK1/2 associates with the c-Met-binding domain of growth factor receptor-bound protein 2 (Grb2)-associated binder-1 (Gab1): role in ERK1/2 and early growth response factor-1 (Egr-1) nuclear accumulation.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15078886","citation_count":38,"is_preprint":false},{"pmid":"14973141","id":"PMC_14973141","title":"Gab1 contributes to cytoskeletal reorganization and chemotaxis in response to platelet-derived growth factor.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14973141","citation_count":37,"is_preprint":false},{"pmid":"20332103","id":"PMC_20332103","title":"The Gab1 scaffold regulates RTK-dependent dorsal ruffle formation through the adaptor Nck.","date":"2010","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/20332103","citation_count":37,"is_preprint":false},{"pmid":"25528308","id":"PMC_25528308","title":"Essential roles of Gab1 tyrosine phosphorylation in growth factor-mediated signaling and angiogenesis.","date":"2014","source":"International journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/25528308","citation_count":36,"is_preprint":false},{"pmid":"28619509","id":"PMC_28619509","title":"miR-141-3p inhibits fibroblast proliferation and migration by targeting GAB1 in keloids.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28619509","citation_count":36,"is_preprint":false},{"pmid":"26517531","id":"PMC_26517531","title":"Cardiac Gab1 deletion leads to dilated cardiomyopathy associated with mitochondrial damage and cardiomyocyte apoptosis.","date":"2015","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/26517531","citation_count":36,"is_preprint":false},{"pmid":"19233262","id":"PMC_19233262","title":"Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells.","date":"2009","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/19233262","citation_count":36,"is_preprint":false},{"pmid":"31944179","id":"PMC_31944179","title":"Gab1 mediates PDGF signaling and is essential to oligodendrocyte differentiation and CNS myelination.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/31944179","citation_count":35,"is_preprint":false},{"pmid":"17284447","id":"PMC_17284447","title":"Hepatocyte growth factor induces glucose uptake in 3T3-L1 adipocytes through A Gab1/phosphatidylinositol 3-kinase/Glut4 pathway.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17284447","citation_count":35,"is_preprint":false},{"pmid":"20435932","id":"PMC_20435932","title":"Scaffolding adaptor protein Gab1 is required for TLR3/4- and RIG-I-mediated production of proinflammatory cytokines and type I IFN in macrophages.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20435932","citation_count":34,"is_preprint":false},{"pmid":"19359598","id":"PMC_19359598","title":"A role for Gab1/SHP2 in thrombin activation of PAK1: gene transfer of kinase-dead PAK1 inhibits injury-induced restenosis.","date":"2009","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/19359598","citation_count":34,"is_preprint":false},{"pmid":"29408807","id":"PMC_29408807","title":"Modifier variant of METTL13 suppresses human GAB1-associated profound deafness.","date":"2018","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/29408807","citation_count":33,"is_preprint":false},{"pmid":"16775003","id":"PMC_16775003","title":"Gab1 is required for cell cycle transition, cell proliferation, and transformation induced by an oncogenic met receptor.","date":"2006","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/16775003","citation_count":33,"is_preprint":false},{"pmid":"28147313","id":"PMC_28147313","title":"MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28147313","citation_count":33,"is_preprint":false},{"pmid":"10593929","id":"PMC_10593929","title":"Activated ERK2 interacts with and phosphorylates the docking protein GAB1.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10593929","citation_count":32,"is_preprint":false},{"pmid":"15679846","id":"PMC_15679846","title":"Host adaptor proteins Gab1 and CrkII promote InlB-dependent entry of Listeria monocytogenes.","date":"2005","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/15679846","citation_count":32,"is_preprint":false},{"pmid":"19350053","id":"PMC_19350053","title":"Crk adaptor protein-induced phosphorylation of Gab1 on tyrosine 307 via Src is important for organization of focal adhesions and enhanced cell migration.","date":"2009","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/19350053","citation_count":32,"is_preprint":false},{"pmid":"17145761","id":"PMC_17145761","title":"Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17145761","citation_count":32,"is_preprint":false},{"pmid":"33786575","id":"PMC_33786575","title":"FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia.","date":"2021","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/33786575","citation_count":31,"is_preprint":false},{"pmid":"23805312","id":"PMC_23805312","title":"Computational Model of Gab1/2-Dependent VEGFR2 Pathway to Akt Activation.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23805312","citation_count":31,"is_preprint":false},{"pmid":"22751113","id":"PMC_22751113","title":"Functional characterization of cancer-associated Gab1 mutations.","date":"2012","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22751113","citation_count":30,"is_preprint":false},{"pmid":"31892308","id":"PMC_31892308","title":"Inhibition of microRNA-29a alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice via upregulation of GAB1.","date":"2019","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/31892308","citation_count":30,"is_preprint":false},{"pmid":"22883624","id":"PMC_22883624","title":"The signaling adaptor GAB1 regulates cell polarity by acting as a PAR protein scaffold.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22883624","citation_count":29,"is_preprint":false},{"pmid":"30016785","id":"PMC_30016785","title":"MicroRNA-29a-3p Downregulation Causes Gab1 Upregulation to Promote Glioma Cell Proliferation.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30016785","citation_count":29,"is_preprint":false},{"pmid":"28738535","id":"PMC_28738535","title":"Role of GAB1/PI3K/AKT signaling high glucose-induced cardiomyocyte apoptosis.","date":"2017","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/28738535","citation_count":29,"is_preprint":false},{"pmid":"24312291","id":"PMC_24312291","title":"Down-regulation of Gab1 inhibits cell proliferation and migration in hilar cholangiocarcinoma.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24312291","citation_count":28,"is_preprint":false},{"pmid":"11376875","id":"PMC_11376875","title":"Role of phosphatidylinositol-3 kinase and its association with Gab1 in thrombopoietin-mediated up-regulation of platelet function.","date":"2001","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/11376875","citation_count":28,"is_preprint":false},{"pmid":"25969544","id":"PMC_25969544","title":"EGFR-activated Src family kinases maintain GAB1-SHP2 complexes distal from EGFR.","date":"2015","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/25969544","citation_count":28,"is_preprint":false},{"pmid":"33393621","id":"PMC_33393621","title":"Circ_0061012 contributes to IL-22-induced proliferation, migration and invasion in keratinocytes through miR-194-5p/GAB1 axis in psoriasis.","date":"2021","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/33393621","citation_count":28,"is_preprint":false},{"pmid":"28081727","id":"PMC_28081727","title":"MicroRNA-200a Suppresses Cell Invasion and Migration by Directly Targeting GAB1 in Hepatocellular Carcinoma.","date":"2017","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/28081727","citation_count":27,"is_preprint":false},{"pmid":"15351743","id":"PMC_15351743","title":"Biochemical and biological responses induced by coupling of Gab1 to phosphatidylinositol 3-kinase in RET-expressing cells.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15351743","citation_count":27,"is_preprint":false},{"pmid":"27530552","id":"PMC_27530552","title":"Targeted nanoconjugate co-delivering siRNA and tyrosine kinase inhibitor to KRAS mutant NSCLC dissociates GAB1-SHP2 post oncogene knockdown.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27530552","citation_count":27,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54989,"output_tokens":14267,"usd":0.189486,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":26199,"output_tokens":7010,"usd":0.153122,"stage2_stop_reason":"end_turn"},"total_usd":0.342608,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"GAB1 interacts directly with the c-Met receptor tyrosine kinase via a proline-rich Met-binding domain (not related to known phosphotyrosine-binding domains); this interaction is specific to c-Met among tested tyrosine kinases. Expression of GAB1 in epithelial cells is sufficient to induce c-Met-specific branching morphogenesis.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, cell-based morphogenesis assay\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal binding experiments, domain mapping, functional rescue in epithelial cells; independently replicated in multiple subsequent studies\",\n      \"pmids\": [\"8906793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Association of GAB1 with the Met/HGF receptor requires a functional Grb2 binding site at tyrosine 1356 (and to a lesser extent Y1349) in the receptor C-terminus; Met receptor mutants impaired in Grb2/GAB1 recruitment fail to induce branching tubulogenesis. GAB1 is the major substrate for the Met kinase in vitro and in vivo.\",\n      \"method\": \"In vitro kinase assay, co-immunoprecipitation with receptor mutants, tubulogenesis assay in MDCK cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro kinase substrate identification, receptor point mutant analysis, functional readout; replicated across labs\",\n      \"pmids\": [\"9252406\", \"9444958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"GAB1 coupling to the Met receptor requires prior binding of Grb2 (both SH2 and SH3 domain-blocking peptides interfere with receptor–GAB1 interaction). GAB1 phosphorylation by Met correlates with the transforming potential of oncogenic Tpr-Met.\",\n      \"method\": \"Point mutations in Met docking site, SH2/SH3 blocking peptides, co-immunoprecipitation, transformation assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal approaches (peptide inhibition + mutational analysis + functional transformation assay), replicated by Nguyen et al. 1997\",\n      \"pmids\": [\"9444958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"GAB1 is tyrosine-phosphorylated in response to IL-6, IL-3, IFN-α, and IFN-γ. Upon IL-6/IL-3 stimulation, GAB1 forms a complex with PI3K and SHP-2. GAB1 overexpression enhances gp130-dependent ERK2 activation; this requires tyrosine 759 (the SHP-2 binding site of gp130) and involves PI3K and Ras.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative PI3K expression, wortmannin inhibition, ERK2 kinase assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (pharmacological inhibition + dominant-negative + mutational analysis), replicated in subsequent studies\",\n      \"pmids\": [\"9632795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"GAB1 is phosphorylated by the insulin receptor (IR) on tyrosine residues; Y472 is the major site for association with p85 (PI3K), with Y447 and Y589 also participating. Y627 is the primary site for SHP-2 SH2 domain binding. The GAB1 PH domain is not required for IR/GAB1 interaction in vitro but is crucial for tyrosine phosphorylation and SHP-2 association in intact cells.\",\n      \"method\": \"Modified yeast two-hybrid, in vitro phosphorylation/pull-down, site-directed mutagenesis\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — yeast two-hybrid + in vitro pull-down + mutagenesis, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"9658397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The GAB1 PH domain binds PtdIns(3,4,5)P3 specifically and mediates GAB1 translocation to the plasma membrane in response to EGF; this translocation is required for efficient GAB1 tyrosine phosphorylation. A positive feedback loop exists in which PI3K is both upstream (generating PtdIns(3,4,5)P3 to recruit GAB1 via PH domain) and downstream (activated by phospho-GAB1) effector. PTEN overexpression inhibits EGF signaling and GAB1 membrane translocation.\",\n      \"method\": \"PH domain–lipid binding assay (PtdIns specificity), membrane translocation by subcellular fractionation/imaging, dominant-interfering PI3K mutant, PTEN overexpression, mutant Gab1 rescue experiments\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (lipid binding, imaging, dominant-negative, PTEN, point mutants); replicated in subsequent studies\",\n      \"pmids\": [\"10648629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The GAB1 PH domain is required for localization of GAB1 at sites of cell–cell contact and for PI3K-dependent epithelial tubulogenesis downstream from the Met receptor. PH-domain deletion causes cytoplasmic mislocalization. LY294002 (PI3K inhibitor) blocks GAB1 membrane localization.\",\n      \"method\": \"Confocal imaging of GFP-tagged GAB1 constructs, LY294002 treatment, tubulogenesis assay with rescue experiments\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct localization experiments, PI3K pharmacological inhibition, functional morphogenesis readout; replicated\",\n      \"pmids\": [\"10022866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"In response to EGF receptor (EGFR) stimulation, GAB1 associates with the EGFR in vivo and in vitro via phosphotyrosines 1068 and 1086 in the EGFR C-terminal tail. GAB1 overexpression potentiates EGF-induced MAPK and JNK activation in a manner requiring PI3K binding.\",\n      \"method\": \"Co-immunoprecipitation (in vivo and in vitro), receptor mutant analysis, PI3K dominant-interfering mutant, wortmannin treatment\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, receptor mapping by mutants, functional pathway activation; multiple orthogonal methods\",\n      \"pmids\": [\"10648629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"EGFR phosphorylates GAB1 at eight tyrosine residues in vitro (Y285, Y373, Y406, Y447, Y472, Y619, Y657, Y689); Y657 is the predominant phosphorylation site and a specific binding site for SHP-2/Syp, as shown by GST pull-down with Y657F mutant abrogating binding.\",\n      \"method\": \"In vitro EGFR kinase assay, phosphopeptide mapping by HPLC/Edman/MS, GST pull-down with cell lysates\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with purified EGFR kinase, mass spectrometry site identification, mutagenesis confirmation; single lab\",\n      \"pmids\": [\"9890893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"GAB1 associates with CRKL via the CRKL SH2 domain and GAB1 YXXP motifs after HGF stimulation; CRKL then engages C3G (via CRKL SH3 domain) to activate the small GTPase Rap1. A GabΔYXXP mutant abolishes HGF-induced Rap1 activation, identifying a HGF→GAB1→CRKL→C3G→Rap1 signaling pathway.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative C3G truncation, Rap1 activation assay, GAB1 YXXP mutant\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, dominant-negative epistasis, GTPase activation assay, mutant GAB1; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"10753869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"GAB1 mediates NGF-independent neurite outgrowth, DNA synthesis, and cell survival in PC12 cells. Constitutively phosphorylated GAB1 induces Akt and MAPK activation; neuritogenesis is abolished by MEK inhibition and partially by PI3K inhibition; survival requires both PI3K and MEK pathways.\",\n      \"method\": \"Recombinant adenovirus-driven GAB1 expression, pharmacological inhibitors (MEK, PI3K), neurite outgrowth assay, MTT survival assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean loss/gain-of-function with specific phenotypic readouts, pathway inhibitors; single lab\",\n      \"pmids\": [\"10601297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"GAB1 is tyrosine-phosphorylated by erythropoietin (EPO) receptor activation and subsequently associates with PI3K (p85), SHP2, SHIP, and SHC; GAB1–Grb2 association increases upon EPO stimulation. GAB1 is the primary IRS-related protein activated by EPO in primary erythroid progenitors.\",\n      \"method\": \"Co-immunoprecipitation, EPO dose-response/time-course phosphorylation, primary cell analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP panel of binding partners, primary cell validation; single lab, no epistasis\",\n      \"pmids\": [\"10194437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The c-Met binding site on GAB1 is localized to a 13-amino acid region unique to GAB1; insertion of this region into Gab2 confers c-Met binding activity. Two Grb2 binding sites were mapped: a classical PXXP motif and a novel PX(V/I)(D/N)RXXKP motif. Association of GAB1 with SHP2 (not PI3K, CRKL, or Shc) is essential for HGF/Met-induced branching morphogenesis in MDCK cells.\",\n      \"method\": \"Reverse yeast two-hybrid technology, phosphorylation-dependent yeast two-hybrid, domain swapping (Gab2 chimera), MDCK branching morphogenesis assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — yeast two-hybrid domain mapping, chimeric protein rescue, functional morphogenesis assay; replicated by multiple labs\",\n      \"pmids\": [\"10871282\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"GAB1-deficient embryos die in utero with defects in heart, placenta, and skin, and show severely reduced ERK MAPK activation in response to HGF, PDGF, EGF, and gp130 stimulation, establishing GAB1 as a common adapter for ERK activation by multiple growth factors and cytokines in vivo.\",\n      \"method\": \"Gab1 gene targeting (knockout mice), ERK activation assay in embryonic cells, phenotypic analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout with biochemical pathway readout and multiple ligand conditions; replicated\",\n      \"pmids\": [\"10779359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Gab1 is essential for c-Met signaling in vivo: Gab1−/− mice phenocopy c-Met mutants in muscle progenitor migration defects (absent forelimb extensor muscles, diaphragm muscle loss), liver size reduction, and placental labyrinth defects. Gab1−/−;c-Met+/− compound mutants show enhanced muscle migration defects, providing genetic epistasis evidence that GAB1 is essential for c-Met signaling.\",\n      \"method\": \"Targeted mutagenesis in mouse, genetic epistasis (double mutant analysis), histological phenotypic analysis\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis in vivo, phenocopy of receptor mutant, compound mutant analysis; replicated\",\n      \"pmids\": [\"10995442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CXCR4 and GAB1 interact genetically in migrating muscle progenitor development: muscle progenitors fail to reach the tongue anlage in CXCR4;Gab1 double mutants but colonize this target in either single mutant, demonstrating cooperative/synergistic genetic interaction.\",\n      \"method\": \"Double-mutant mouse analysis, genetic epistasis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic epistasis in vivo; single study\",\n      \"pmids\": [\"16166380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Phosphotyrosines 627 and 659 of GAB1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) that binds SHP2 tandem SH2 domains in a specific orientation (N-SH2→pY627, C-SH2→pY659) and activates SHP2 phosphatase activity. GAB1 is also a substrate of SHP2 (dephosphorylated by SHP2 in vitro and confirmed by substrate-trapping in cells). Physical association of active SHP2 with GAB1 (not just SHP2 activity alone) is necessary and sufficient for ERK2 activation.\",\n      \"method\": \"Far Western blot (tandem SH2 orientation), in vitro SHP2 phosphatase assay with bisphosphopeptides, substrate-trapping with catalytically inactive SHP2, chimeric Gab1FF-SHP2ΔN rescue\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of SHP2 activation, far Western mapping, substrate-trapping, chimeric rescue; multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"11323411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Activated ERK2 directly associates with GAB1 via the Met-binding domain (MBD) exclusively in its phosphorylated form; GAB1 is an ERK2 substrate in vitro and shows increased serine phosphorylation in cells co-expressing constitutively active MEK1. ERK-mediated phosphorylation of GAB1 at a threonine adjacent to the pY472 site (pYT peptide) increases affinity for p85 PI3K, providing positive feedback (HGF context).\",\n      \"method\": \"GST pull-down with purified pERK2 vs non-pERK2, co-immunoprecipitation in intact cells, in vitro kinase assay, phosphopeptide competition/pull-down assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro reconstitution with purified kinase, co-IP in cells, peptide biochemistry; single lab, two orthogonal methods\",\n      \"pmids\": [\"10593929\", \"11445578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"ERK negatively regulates GAB1 tyrosine phosphorylation and GAB1/PI3K interaction in the EGF (but not HGF) context: MEK inhibition by U0126 increases EGF-stimulated GAB1 tyrosine phosphorylation, SHP2 association, and GAB1/p85 association and PI3K/Akt activation. SHP2 dephosphorylates GAB1, suggesting EGF-stimulated ERK acts through SHP2 to reduce GAB1 phosphorylation.\",\n      \"method\": \"MEK inhibitor (U0126), co-immunoprecipitation, GST-p85 pull-down, pervanadate treatment, dominant-negative SHP2\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological and dominant-negative epistasis, Co-IP; single lab, multiple conditions\",\n      \"pmids\": [\"11896055\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PKC-α and PKC-β1 mediate serine/threonine hyperphosphorylation of GAB1 (upon PP1/PP2A inhibition by okadaic acid), which suppresses GAB1 tyrosine phosphorylation and its recruitment of PI3K, providing a negative-feedback mechanism for HGF/Met receptor signaling.\",\n      \"method\": \"Okadaic acid treatment, PKC isoform-specific inhibitors/activators, co-immunoprecipitation, phosphoamino acid analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological dissection of kinase isoforms + biochemical readout; single lab\",\n      \"pmids\": [\"11313945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"ERK regulates the HGF-mediated GAB1/PI3K interaction positively: ERK inhibition reduces HGF-stimulated association of Gab1 with p85 and decreases Akt activation; a phosphothreonine+phosphotyrosine (pYT) peptide at the GAB1 YVPM motif shows higher affinity for p85 than phosphotyrosine alone, indicating ERK-phosphorylated threonine at T476 augments PI3K recruitment.\",\n      \"method\": \"MEK inhibitor, GST-p85 pull-down, co-immunoprecipitation, synthetic pY and pYT peptide competition assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro peptide biochemistry + cell Co-IP + pharmacological epistasis; single lab, orthogonal methods\",\n      \"pmids\": [\"11445578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"GAB1 forms complexes with p85 PI3K and SHP2 upon Met transformation; Crk associates with Gab1 (not p130Cas/paxillin) in Met-transformed cells and in suspension-grown cells, and Gab1-Crk coupling activates JNK in anchorage-independent conditions.\",\n      \"method\": \"Co-immunoprecipitation in adherent and suspension conditions, JNK activation assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP in multiple conditions, JNK readout; single lab\",\n      \"pmids\": [\"11146548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GAB1 recruits SHP2 to dephosphorylate paxillin, causing dissociation of Csk from paxillin, which dephosphorylates Src Y530 and activates Src. This Gab1→SHP2→paxillin dephosphorylation→Src activation pathway is required for EGF-induced ERK activation and cell migration; SHP2-binding-defective Gab1FF blocks all these events.\",\n      \"method\": \"Co-immunoprecipitation, SHP2 substrate assay (paxillin dephosphorylation in vitro and in cells), Src Y530 phosphorylation analysis, cell migration assay, dominant-negative SHP2\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro phosphatase assay on paxillin + mutant Gab1 + dominant-negative SHP2 + migration readout; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"14665621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GAB1 and SHP2 promote Ras/MAPK activity in epidermis: Gab1-deficient epidermis shows lower active Ras and MAPK levels; Gab1Y627F (SHP2-binding-defective) reduces basal Ras and triggers differentiation; these effects are rescued by active Ras, placing GAB1/SHP2 upstream of Ras.\",\n      \"method\": \"Gab1−/− mouse epidermis, dominant-negative SHP2, Gab1Y627F mutant, activated Ras rescue, human epidermis organotypic culture\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout + epistasis (Ras rescue) + tissue-level functional readout; replicated\",\n      \"pmids\": [\"12370245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"IGF-1 downregulates GAB1 expression in endothelial cells; GAB1 associates with MEKK3 and inhibits MEKK3-induced c-Jun and NF-κB transcriptional activation; catalytically inactive MEKK3 also inhibits TNF-α-induced c-Jun and NF-κB activation, implicating the GAB1-MEKK3 complex in TNF-α signaling.\",\n      \"method\": \"Co-immunoprecipitation (Gab1-MEKK3), reporter assays (c-Jun, NF-κB), dominant-negative MEKK3, Western blot for Gab1 expression\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP of novel interaction + reporter assay + dominant-negative epistasis; single lab\",\n      \"pmids\": [\"12065326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Met-activated Gab1 directly interacts with cortactin via Gab1 proline-rich motifs P4/5 and the cortactin SH3 domain; this Gab1-cortactin complex is required for Met-mediated invadopodia formation and cell invasion. Uncoupling cortactin from Gab1 (via P4/5 mutations) abrogates invadopodia and invasion.\",\n      \"method\": \"Gab1-null fibroblasts, Gab1 siRNA in tumor cells, structure-function (P4/5 deletion mutants), direct interaction assay (cortactin SH3 pull-down), invadopodia assay, invasion assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Gab1-null cells + siRNA + domain mutants + direct interaction mapping + functional invasion readout; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"22366451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Grb2-independent recruitment of Gab1 to Met requires a 16-amino acid motif within the Gab1 Met-binding domain (MBD) and the structural integrity of the Met kinase domain C-terminal lobe including residues upstream of pY1349; substitution of Y1349 with an acidic residue (phosphomimetic) allows Gab1 MBD recruitment and Gab1 phosphorylation.\",\n      \"method\": \"Met kinase domain mutants, deletion mapping of Gab1 MBD (16-aa minimal motif), co-immunoprecipitation, in vitro binding\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain mapping, kinase mutants, binding assay; single lab\",\n      \"pmids\": [\"12766170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ERK1/2 phosphorylates GAB1 at six serine/threonine residues (T312, S381, S454, T476, S581, S597) in vitro; S454, S581, S597, T476 account for ~80% of incorporated phosphate. These ERK phosphorylation sites are located adjacent to PI3K-binding YVPM motifs and their phosphorylation blocks PI3K and Akt activity in intact cells (insulin signaling context).\",\n      \"method\": \"In vitro ERK1/2 kinase assay, 2D-HPLC phosphopeptide mapping, MALDI-MS + Edman sequencing, PI3K/Akt activity assays in cells\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay + mass spectrometry site identification + functional PI3K/Akt readout in cells; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"15379552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"EGF ligand binding increases EGFR kinase affinity (lowers Km ~4-6-fold) for Gab1 Y627 and Shc Y317 peptides while increasing kcat ~5-fold for all peptides, resulting in ~15–40-fold increase in specificity constants for these substrates vs ~5-fold for EGFR autophosphorylation sites. EGF significantly enhances Gab1 Y627 and Shc Y317 phosphorylation relative to EGFR autophosphorylation in cell lysates.\",\n      \"method\": \"Steady-state enzyme kinetics with synthetic peptides, purified EGFR, GST fusion protein binding assay, cell lysate phosphorylation comparison\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase kinetics with purified enzyme, multiple peptide substrates, cell lysate validation; single lab, rigorous biochemical study\",\n      \"pmids\": [\"15231819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Noonan syndrome SHP2 mutants show increased basal phosphatase activity and prolonged, EGF-dependent binding to GAB1 with sustained tyrosine phosphorylation of both proteins. Coexpression of Gab1-FF (lacking SHP2 binding motifs) blocks EGF-mediated increase in SHP2 phosphatase activity and dramatically reduces ERK2 activation, demonstrating that docking through GAB1 is required for Noonan syndrome SHP2 mutant-driven sustained ERK2 activation.\",\n      \"method\": \"Phosphatase activity assay, co-immunoprecipitation time-course, Gab1-FF dominant-negative, ERK2 activation assay, cell proliferation assay\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — enzyme activity assay + Co-IP + dominant-negative epistasis + proliferation readout; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"14974085\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GAB1 is the primary mediator of EGF-stimulated PI3K/Akt activation: Gab1−/− MEFs show severely impaired EGF-induced PI3K and Akt activation; three canonical GAB1 tyrosine phosphorylation sites mediate p85 complex formation. SHP2 association with GAB1 negatively regulates GAB1-mediated PI3K/Akt activation following EGFR stimulation.\",\n      \"method\": \"Gab1−/− MEFs, rescue with GAB1 mutants, PI3K assay, Akt phosphorylation, co-immunoprecipitation\",\n      \"journal\": \"BMC biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout plus mutant rescue with specific readouts; replicated\",\n      \"pmids\": [\"15550174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SHP2 dephosphorylates YXXP motifs on GAB1 (including Y317-containing motif) to prevent RasGAP binding; when SHP2 is inactive, RasGAP binds phospho-Y317 on GAB1, relocates to the membrane, and inhibits Ras. A RasGAP-inactive mutant restores Ras activation in SHP2-deficient or Gab1-SHP2-binding-defective cells. GAB1 interacts with RasGAP SH2 domains via pY317.\",\n      \"method\": \"Substrate-trapping SHP2 mutant, Gab1 YXXP deletion mutant, RasGAP-inactive mutant rescue, RasGAP relocalization by fractionation, Ras activation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — substrate-trapping + deletion mutant + inactive mutant rescue + Ras activation readout; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"15574420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Laminar flow-induced GAB1 tyrosine phosphorylation is Src kinase-dependent and VEGFR2-dependent; phospho-GAB1 associates with p85 PI3K; a GAB1 mutant lacking p85 binding sites or Gab1 siRNA knockdown inhibits flow-induced Akt and eNOS activation.\",\n      \"method\": \"Src inhibitor PP2, VEGFR2 kinase inhibitors, co-immunoprecipitation, siRNA knockdown, Akt/eNOS phosphorylation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibitors + siRNA + mutant GAB1 + functional readouts; single lab\",\n      \"pmids\": [\"15665327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Fluid shear stress-induced eNOS activation depends on GAB1-SHP2 interaction: mutation of GAB1 Y627F prevents shear-induced eNOS phosphorylation (but not Akt); dominant-negative SHP2 prevents PKA activation and eNOS phosphorylation. GAB1, SHP2, eNOS, and PKA catalytic subunit form a signalosome complex under shear. GAB1 PH domain is required for shear-induced Akt phosphorylation but not eNOS activation.\",\n      \"method\": \"GAB1 Y627F mutant, dominant-negative SHP2, co-immunoprecipitation of signalosome, PKA inhibitor, isolated murine carotid arteries (ex vivo validation)\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-immunoprecipitation of complex + multiple mutants + ex vivo vascular functional readout; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"16284184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Hck (hematopoietic cell kinase), a Src family kinase, phosphorylates GAB1 and GAB2 in response to IL-6 in multiple myeloma cells; PP2 (Src family inhibitor) and kinase-inactive Hck mutants reduce IL-6-triggered GAB1 tyrosine phosphorylation, ERK activation, and Akt activation, impairing myeloma cell proliferation and survival.\",\n      \"method\": \"Kinase-inactive Hck mutant expression, Src family kinase inhibitor PP2, co-immunoprecipitation, ERK/Akt assays, cell proliferation/survival assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinase-inactive mutant + pharmacological inhibitor + functional readouts; single lab\",\n      \"pmids\": [\"15010462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GAB1 and SHP2 association is a critical event in liver regeneration: partial hepatectomy induces assembly of a Gab1-SHP2 complex in hepatocytes; liver-specific Gab1 knockout (LGKO) mice show defective ERK1/2 activation, decreased immediate-early gene expression, reduced cyclin levels, and suppressed hepatocyte proliferation after partial hepatectomy—phenocopying liver-specific Shp2 knockout mice.\",\n      \"method\": \"Liver-specific conditional Gab1 knockout, co-immunoprecipitation, ERK1/2 activation assay, gene expression analysis, BrdU proliferation assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout phenocopying Shp2 KO, co-IP, multiple downstream readouts; replicated\",\n      \"pmids\": [\"16738330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GAB1 is required for VEGF-induced endothelial cell migration and capillary formation; GAB1 siRNA impairs PLCγ, ERK1/2, Src, and Akt activation by VEGF. GAB1 associates with VEGFR2, Grb2, PI3K, SHP2, Shc, and PLCγ in VEGF-stimulated cells; GAB1 mutants unable to bind SHP2 or PI3K mimic GAB1 depletion defects.\",\n      \"method\": \"siRNA knockdown, co-immunoprecipitation panel, overexpression of mutant GAB1, migration assay, tube formation assay, actin reorganization imaging\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA + mutant GAB1 + functional assays; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"17178724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Knockin mouse analysis demonstrates distinct in vivo requirements: PI3K recruitment by GAB1 is essential for EGFR-mediated eyelid closure and keratinocyte migration, while GAB1-SHP2 interaction is essential for Met-directed placental development and muscle progenitor limb migration. Either direct (via Met-binding domain) or indirect (via Grb2) GAB1 recruitment to Met is sufficient for muscle precursor migration, but both modes are required for placenta, liver growth, and palate development.\",\n      \"method\": \"Knockin mice with point mutations in PI3K, SHP2, Grb2, and Met-binding sites of Gab1; developmental phenotypic analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple in vivo knockin alleles with distinct phenotypic readouts; rigorous genetic epistasis study\",\n      \"pmids\": [\"17881575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A new mechanism for Gab1 plasma membrane recruitment: ERK-dependent phosphorylation of Ser551 in Gab1 is required for its translocation to the plasma membrane; PI3K activity alone is insufficient. MAPK-dependent Ser551 phosphorylation represents a novel regulatory mode for PH domain function.\",\n      \"method\": \"ERK inhibitor, Ser551 phosphomutants, membrane fractionation/localization assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological ERK inhibition + phosphosite mutants + subcellular fractionation; single lab\",\n      \"pmids\": [\"19050043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Pak4 is a novel Gab1-binding partner: Gab1 and Pak4 associate after HGF stimulation and colocalize at lamellipodia; the interaction requires Gab1 phosphorylation but not Pak4 kinase activity; it is mediated by a unique Gab1 region (no homology to known interaction motifs) and the GEF-interacting domain of Pak4. Gab1/Pak4 synergize in epithelial dispersal, migration, and invasion; a Pak4-binding-defective Gab1 mutant fails to promote these responses.\",\n      \"method\": \"Co-immunoprecipitation, colocalization imaging, Pak4 siRNA knockdown, Gab1 mutant lacking Pak4-binding region, migration/invasion assays, morphogenesis assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — novel interaction mapped + siRNA + mutant Gab1 + functional assays; single lab\",\n      \"pmids\": [\"19289496\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crk SH2 domain mediates Gab1 interaction and recruits Src to phosphorylate Gab1 at Y307; this requires Src specifically (not Yes/Fyn). Gab1-Y307F mutant fails to localize near the plasma membrane upon HGF stimulation and reduces cell migration, focal adhesion formation, and localization of Crk, FAK, and paxillin.\",\n      \"method\": \"Crk/SH2 mutants, Src/Yes/Fyn triple-knockout fibroblasts, PP2 Src inhibitor, Y307F Gab1 mutant, focal adhesion imaging, cell migration assay\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic (triple KO fibroblasts) + pharmacological + mutant + functional readouts; single lab\",\n      \"pmids\": [\"19350053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"GAB1 scaffold is essential for dorsal ruffle formation downstream of Met, EGF, and PDGF receptors; GAB1 constitutively associates with N-WASP and recruits Nck into a dorsal-ruffle-localized complex upon RTK activation. Gab1ΔNck (Y407F) mutant fails to recruit Nck, prevents dorsal ruffles, decreases Met-dependent Rac activation, and impairs cell migration and epithelial remodeling.\",\n      \"method\": \"Gab1-null fibroblasts, co-immunoprecipitation (Gab1-N-WASP, Gab1-Nck), Gab1 Y407F mutant, dorsal ruffle quantification, Rac activation assay, migration assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — null cells + novel interaction (N-WASP, Nck) + mutant + Rac GTPase assay + functional readouts; single lab\",\n      \"pmids\": [\"20332103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Endothelium-specific Gab1 knockout mice show impaired postnatal ischemic angiogenesis; HGF induces Gab1-SHP2 complex formation required for EC migration/proliferation via ERK1/2 and ERK5, and Gab1-p85 complex contributes to Akt activation and partial migration. HGF upregulates angiogenic genes (KLF2, Egr1) via Gab1-SHP2 complex.\",\n      \"method\": \"Endothelium-specific Gab1 KO mice, hindlimb ischemia model, co-immunoprecipitation, ERK1/2/5 assays, VEGF vs HGF gene transfer rescue, microarray\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO + in vivo ischemia model + gene transfer rescue + biochemical pathway mapping; multiple orthogonal methods\",\n      \"pmids\": [\"21293003\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Endothelium-specific Gab1 KO mice have impaired VEGF-induced eNOS activation and angiogenesis; Gab1/SHP2 association is required for PKA activation and eNOS phosphorylation; active PKA rescues VEGF-induced eNOS activation in EGKO ECs. Gab1/SHP2 interaction is required for tube formation in vitro and ischemic angiogenesis in vivo.\",\n      \"method\": \"Endothelium-specific Gab1 KO mice, Matrigel plug assay, co-IP, active PKA rescue, eNOS activation assay, tube formation assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO + active PKA rescue + multiple functional and biochemical readouts; replicated across labs\",\n      \"pmids\": [\"21282639\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GAB1 acts as a PAR protein scaffold: GAB1 directly interacts with PAR1 and PAR3; GAB1 binding enhances PAR1 kinase activity; GAB1 brings PAR1 and PAR3 into a transient complex promoting PAR3 phosphorylation by PAR1. GAB1 and PAR6 compete for PAR3 PDZ1 binding. GAB1 depletion causes PAR3 hypophosphorylation, increased PAR3/PAR6 complex, and accelerated tight junction formation. GAB1 overexpression disrupts apical-basal polarity and promotes multilumen cyst formation in a PAR1/PAR3-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation, PAR1 kinase assay, domain competition assay (GAB1 vs PAR6 for PAR3 PDZ1), siRNA knockdown, overexpression, transepithelial resistance assay, 3D cyst morphogenesis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — kinase assay, domain binding competition, siRNA/OE with multiple functional readouts; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"22883624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Gαi1/3 are required for KGF (FGF-7) activation of PI3K-AKT-mTORC1 through GAB1: upon KGF stimulation, Gαi1/3 form a complex with KGFR and are required for subsequent GAB1 recruitment, phosphorylation, and PI3K-p85 activation. Gαi1/3 shRNA knockdown inhibits KGF-induced cell proliferation, migration, and cyclin D1/fibronectin accumulation.\",\n      \"method\": \"Co-immunoprecipitation (Gαi1/3-KGFR-GAB1 complex), shRNA knockdown, PI3K/Akt/mTOR activity assays, cell proliferation and migration assays\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP complex + shRNA + functional readouts; single lab\",\n      \"pmids\": [\"25078664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"EGF promotes SHP2 binding to tyrosine-phosphorylated GAB1, activating SHP2, which augments TGFβ-induced EMT. Knockdown of SHP2 and reconstitution with phosphotyrosine-binding-impaired SHP2 eliminates EGF-mediated EMT augmentation, demonstrating that physical SHP2 recruitment to GAB1 (not just SHP2 catalytic activity per se) is required.\",\n      \"method\": \"siRNA knockdown + SHP2 mutant rescue, co-immunoprecipitation, E-cadherin/vimentin expression, cell scatter assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA + domain-binding-dead mutant rescue + Co-IP + functional readouts; single lab\",\n      \"pmids\": [\"26359300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"EGFR-activated Src family kinases (SFKs) maintain GAB1 phosphorylation and GAB1-SHP2 complexes at a cytosolic site distal from EGFR; a delay in SFK inactivation after EGFR inactivation prolongs GAB1-SHP2 complex persistence beyond EGFR phosphorylation. This SFK-dependent mechanism is specific to EGFR and does not occur downstream of c-MET.\",\n      \"method\": \"Quantitative co-immunoprecipitation time-course, SFK inhibitors, computational modeling validated by experiment, EGFR vs c-MET comparison\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative biochemical time-course + pharmacological + computational model validation; single lab\",\n      \"pmids\": [\"25969544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Gab1 is required for normal hair cycle and hair follicle stem cell (HFSC) quiescence: conditional Gab1 knockout (K14-Cre or Krox20-Cre) prevents catagen entry; HFSCs lose quiescence and become exhausted. Conditional expression of gain-of-function Mek1(DD) (by Krox20-Cre) rescues hair cycle deficits and restores HFSC quiescence, placing GAB1 upstream of Shp2 and MAPK in this pathway.\",\n      \"method\": \"Conditional Gab1 knockout mice, Mek1(DD) gain-of-function knockin rescue, HFSC quantification, hair cycle analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO + gain-of-function genetic rescue with pathway placement; rigorous in vivo epistasis\",\n      \"pmids\": [\"26456821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The non-receptor tyrosine kinase FER phosphorylates Met at Tyr1349 in an HGF-independent and Met autophosphorylation-independent manner; this promotes GAB1 recruitment and phosphorylation and activates the SHP2-ERK signaling pathway specifically (without activating Akt), thereby promoting ovarian cancer cell motility, invasion, and metastasis.\",\n      \"method\": \"FER siRNA/shRNA, phosphosite-specific antibodies, co-immunoprecipitation, kinase assay, cell migration/invasion, in vivo metastasis model\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — novel kinase identified with siRNA + in vivo model + biochemical pathway specificity; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"27401557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A p.Gly116Glu substitution in the GAB1 PH domain causes DFNB26 recessive profound deafness. METTL13 (dominant modifier DFNM1; p.Arg544Gln) coimmunoprecipitates with GAB1 and SPRY2, forming at least a tripartite complex; METTL13 modifier allele rescues GAB1 morphant phenotype in zebrafish. GAB1 p.Gly116Glu mutation dysregulates HGF, MET, SHP2, and SPRY2 expression; SPRY2 dysregulation is corrected in the presence of the METTL13 suppressor.\",\n      \"method\": \"Co-immunoprecipitation (METTL13-GAB1-SPRY2 complex), zebrafish morpholino rescue with human mRNA, gene expression profiling in human lymphoblastoid cells, human genetic mapping\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP of tripartite complex + zebrafish rescue + human cell expression analysis + genetic mapping; multiple orthogonal methods\",\n      \"pmids\": [\"29408807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GAB1 is an essential effector of PDGF signaling in oligodendrocyte precursor cells (OPCs): conditional Gab1 deletion causes CNS hypomyelination by impairing OPC differentiation. GAB1 binds downstream to GSK3β and regulates its activity, thereby affecting β-catenin nuclear accumulation and expression of myelination-related transcription factors.\",\n      \"method\": \"Conditional Gab1 knockout in oligodendrocyte lineage, GSK3β binding (co-immunoprecipitation), β-catenin localization, transcription factor expression analysis, myelin staining\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO + novel binding partner (GSK3β) + downstream pathway readout; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"31944179\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GAB1 is a scaffold/docking protein that is recruited to multiple receptor tyrosine kinases (c-Met, EGFR, VEGFR2, PDGFR, RET, EpoR, gp130) via direct binding to the Met kinase domain through a unique 13-aa Met-binding domain (MBD) or indirectly through constitutive Grb2 association; upon receptor activation it is tyrosine-phosphorylated (by the receptor kinase or by Src family kinases such as Hck/Src/FER), and its phospho-YXXP motifs recruit SHP2 (via a bisphosphoryl BTAM at pY627/pY659), PI3K-p85 (via pY472/pY447), Crk/CRKL, RasGAP, cortactin, Nck, PAR1, and GSK3β; GAB1 acts as a positive feedback amplifier by using its PH domain to bind PI3K-generated PtdIns(3,4,5)P3 for membrane translocation, and it is negatively regulated by ERK-mediated serine/threonine phosphorylation (blocking PI3K binding), by SHP2-mediated dephosphorylation of its own tyrosines (including pY317 to disengage RasGAP and sustain Ras), and by PKC-mediated serine/threonine hyperphosphorylation; through these interactions GAB1 is essential for ERK/MAPK, PI3K/Akt, Src, Rac1/PAK, Rap1, and PKA/eNOS activation downstream of growth factors and cytokines, and in vivo is required for muscle progenitor migration, placental labyrinth development, liver regeneration, epithelial morphogenesis, hair follicle stem cell quiescence, CNS myelination, angiogenesis, and hearing (where a PH-domain p.Gly116Glu mutation causes DFNB26 deafness suppressed by a METTL13-GAB1-SPRY2 tripartite complex).\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GAB1 is a cytoplasmic scaffold/docking protein that couples diverse receptor tyrosine kinases and cytokine receptors to the ERK/MAPK and PI3K/Akt pathways, and is required in vivo for multiple growth-factor-dependent developmental and regenerative processes including muscle progenitor migration, placental and liver development, epithelial morphogenesis, angiogenesis, hair follicle stem cell quiescence, and CNS myelination [#13, #14, #37, #48, #51]. It engages the c-Met receptor both directly, through a unique Met-binding domain whose 13-amino-acid core is sufficient to confer Met binding, and indirectly through constitutive Grb2 association at Met phosphotyrosine 1356 [#0, #1, #2, #12, #26], while related recruitment to EGFR occurs via receptor phosphotyrosines 1068/1086 [#7]. Upon receptor engagement GAB1 is tyrosine-phosphorylated by the receptor kinase or by Src-family kinases (Hck, Src) and the non-receptor kinase FER [#1, #34, #40, #49], generating docking sites that recruit SHP2 through a bisphosphoryl tyrosine-based activation motif at pY627/pY659 that orients and activates the SHP2 tandem SH2 domains, and that recruit PI3K-p85 through YVPM motifs [#8, #16, #4, #30]. GAB1-bound SHP2 drives Ras/ERK activation by dephosphorylating substrates such as paxillin (relieving Csk to activate Src) and by removing the RasGAP docking site at GAB1 pY317, thereby sustaining Ras [#22, #31, #23]. GAB1 amplifies its own activation through a positive feedback loop in which its PH domain binds PI3K-generated PtdIns(3,4,5)P3 to translocate to the plasma membrane and to cell-cell contacts, a step required for efficient phosphorylation and morphogenesis [#5, #6]. GAB1 signaling is negatively regulated by ERK-mediated serine/threonine phosphorylation adjacent to PI3K-binding motifs and by PKC-mediated serine/threonine hyperphosphorylation, both of which suppress tyrosine phosphorylation and PI3K recruitment [#27, #18, #19]. Beyond these core modules, GAB1 nucleates cytoskeletal and polarity complexes by recruiting cortactin, Nck/N-WASP, Pak4, and CRKL to drive invadopodia, dorsal ruffles, Rac and Rap1 activation, and cell migration [#25, #41, #39, #9], and acts as a scaffold organizing PAR1/PAR3 in epithelial polarity [#44]. A GAB1 PH-domain p.Gly116Glu mutation causes DFNB26 recessive deafness, with a METTL13 modifier allele that forms a METTL13-GAB1-SPRY2 complex suppressing the phenotype [#50].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established GAB1 as a direct c-Met-binding scaffold and showed it could drive a receptor-specific morphogenetic program, defining its role as a Met effector rather than a generic adapter.\",\n      \"evidence\": \"Co-immunoprecipitation, domain mapping, and branching morphogenesis assay in epithelial cells\",\n      \"pmids\": [\"8906793\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve whether Met binding is direct in vivo versus Grb2-mediated\", \"Downstream effectors not yet identified\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Resolved the receptor-coupling architecture by showing GAB1 recruitment to Met requires the Grb2 binding site (Y1356) and that GAB1 is the principal Met kinase substrate, linking recruitment to function via tubulogenesis and transformation.\",\n      \"evidence\": \"In vitro kinase assay, receptor point mutants, MDCK tubulogenesis, SH2/SH3 blocking peptides, transformation assay\",\n      \"pmids\": [\"9252406\", \"9444958\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map GAB1 phosphosites or downstream binding partners\", \"Direct vs Grb2-dependent contributions not separated\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Generalized GAB1 beyond Met by showing tyrosine phosphorylation and SHP2/PI3K complex formation downstream of cytokine (gp130/IL-6, IL-3) and insulin receptors, and mapped the major PI3K (Y472) and SHP2 (Y627) docking tyrosines.\",\n      \"evidence\": \"Co-IP, dominant-negative PI3K, wortmannin, ERK assays, yeast two-hybrid and in vitro phosphorylation/mutagenesis\",\n      \"pmids\": [\"9632795\", \"9658397\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which SHP2 promotes ERK not yet defined\", \"Membrane recruitment mechanism unaddressed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defined the PH-domain/PtdIns(3,4,5)P3 positive-feedback loop for membrane recruitment and extended GAB1 to EGFR, mapping additional phosphosites (Y657 for SHP2), and connected GAB1 to Rap1 (via CRKL/C3G) and to survival/differentiation outputs.\",\n      \"evidence\": \"PH-lipid binding, GFP imaging, PI3K dominant-negative, PTEN overexpression, EGFR mutant Co-IP, phosphopeptide mapping, CRKL/C3G epistasis, PC12 phenotypic assays\",\n      \"pmids\": [\"10648629\", \"10022866\", \"9890893\", \"10753869\", \"10601297\", \"10194437\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of the feedback loop not quantified\", \"Relative contribution of each phosphosite in vivo unclear\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Pinpointed the minimal 13-aa Met-binding determinant unique to GAB1 and demonstrated genetically that GAB1 is an obligate Met effector in vivo, with SHP2 (not PI3K/CRKL/Shc) coupling being essential for branching morphogenesis.\",\n      \"evidence\": \"Reverse/phosphorylation-dependent yeast two-hybrid, Gab2 domain-swap chimeras, Gab1 knockout mice with multi-ligand ERK assays and epistasis with c-Met\",\n      \"pmids\": [\"10871282\", \"10779359\", \"10995442\", \"16166380\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why SHP2 coupling is selectively essential not mechanistically explained at this stage\", \"Tissue-specific effector requirements not yet dissected\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Elucidated the SHP2 activation mechanism (pY627/pY659 bisphosphoryl BTAM activating the tandem SH2) and uncovered bidirectional ERK feedback plus PKC negative regulation, establishing GAB1 as a regulated signaling hub.\",\n      \"evidence\": \"Far Western SH2 orientation mapping, in vitro SHP2 phosphatase assays, substrate-trapping, chimeric rescue, MEK inhibitors, pYT peptide affinity assays, PKC isoform inhibitors\",\n      \"pmids\": [\"11323411\", \"10593929\", \"11445578\", \"11896055\", \"11313945\", \"11146548\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Context-dependence of ERK feedback (HGF vs EGF) left partly unresolved\", \"Phosphatase substrates of GAB1-bound SHP2 not yet identified\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identified the SHP2 substrate arm that drives ERK: GAB1-SHP2 dephosphorylates paxillin to activate Src, and demonstrated GAB1/SHP2 acts upstream of Ras/MAPK in epidermis with active Ras as a rescue.\",\n      \"evidence\": \"In vitro and cellular paxillin dephosphorylation, Src Y530 analysis, migration assays, Gab1-null epidermis with Gab1Y627F and activated Ras rescue, MEKK3 Co-IP/reporters\",\n      \"pmids\": [\"14665621\", \"12370245\", \"12065326\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether paxillin is the sole relevant SHP2 substrate unclear\", \"MEKK3/NF-kB arm not connected to canonical ERK module\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined the second SHP2 substrate mechanism — dephosphorylation of GAB1 pY317 to evict RasGAP and sustain Ras — and mapped the ERK-driven inhibitory serine/threonine sites adjacent to PI3K motifs, plus quantified EGFR substrate preference for GAB1.\",\n      \"evidence\": \"Substrate-trapping SHP2, RasGAP-inactive rescue, in vitro ERK kinase + MS phosphosite mapping, EGFR enzyme kinetics, Gab1-null MEFs, Noonan SHP2 mutant Co-IP\",\n      \"pmids\": [\"15574420\", \"15379552\", \"15231819\", \"15550174\", \"14974085\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo importance of each ERK-target serine not tested individually\", \"Integration of positive and negative ERK feedback not unified\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Extended GAB1 to mechanotransduction and additional kinases, showing Src/VEGFR2-dependent GAB1 phosphorylation drives Akt/eNOS and that a GAB1-SHP2-eNOS-PKA signalosome controls eNOS, while Hck phosphorylates GAB1 in myeloma.\",\n      \"evidence\": \"Src/VEGFR2 inhibitors, siRNA, GAB1 mutants, signalosome Co-IP, ex vivo carotid arteries, PKA inhibitor, kinase-inactive Hck\",\n      \"pmids\": [\"15665327\", \"16284184\", \"15010462\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How PKA is activated within the signalosome not fully resolved\", \"Tissue specificity of Hck vs Src usage unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrated physiological GAB1-SHP2 requirements in liver regeneration and VEGF-driven endothelial migration via conditional knockouts that phenocopy Shp2 loss.\",\n      \"evidence\": \"Liver-specific Gab1 knockout with partial hepatectomy, proliferation and gene expression readouts; VEGFR2 siRNA and mutant GAB1 in endothelial migration/tube assays\",\n      \"pmids\": [\"16738330\", \"17178724\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative roles of SHP2 vs PI3K arms not separated in these tissues\", \"Upstream receptor identity in regeneration not fully defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Used knockin alleles to genetically separate GAB1 effector modules in vivo, showing PI3K coupling is required for EGFR-driven eyelid/keratinocyte functions while SHP2 coupling is required for Met-driven placenta and muscle migration.\",\n      \"evidence\": \"Knockin mice with point mutations in PI3K, SHP2, Grb2 and Met-binding sites; developmental phenotyping\",\n      \"pmids\": [\"17881575\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis for why different tissues require different arms not explained\", \"Redundancy with Gab2 not addressed\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Revealed a PI3K-independent route to membrane recruitment via ERK-dependent Ser551 phosphorylation, refining the model of PH-domain regulation.\",\n      \"evidence\": \"ERK inhibitor, Ser551 phosphomutants, membrane fractionation\",\n      \"pmids\": [\"19050043\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How Ser551 phosphorylation alters PH-domain behavior is unresolved\", \"Relative contribution vs PtdIns(3,4,5)P3 recruitment not quantified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Expanded GAB1's cytoskeletal/migration interactome by identifying Pak4 and Crk-recruited Src (phosphorylating GAB1 Y307) as drivers of lamellipodia, focal adhesion dynamics, and migration.\",\n      \"evidence\": \"Co-IP, colocalization, Pak4/Crk mutants, Src/Yes/Fyn triple-knockout fibroblasts, PP2, Gab1 point mutants, migration/invasion assays\",\n      \"pmids\": [\"19289496\", \"19350053\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of the Pak4-binding region undefined\", \"In vivo relevance of Y307 not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showed GAB1 nucleates a dorsal-ruffle actin module by constitutively binding N-WASP and recruiting Nck (via Y407) to activate Rac downstream of multiple RTKs.\",\n      \"evidence\": \"Gab1-null fibroblasts, Co-IP, Gab1 Y407F mutant, dorsal ruffle quantification, Rac activation and migration assays\",\n      \"pmids\": [\"20332103\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Quantitative link between Rac activation and morphogenesis incomplete\", \"Single-lab characterization of the Nck/N-WASP module\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined a non-canonical GAB1 role as a PAR-polarity scaffold that bridges PAR1 and PAR3 to control PAR3 phosphorylation, tight junction formation, and apical-basal polarity.\",\n      \"evidence\": \"Co-IP, PAR1 kinase assay, GAB1-vs-PAR6 PDZ1 competition, siRNA/overexpression, TER and 3D cyst morphogenesis assays\",\n      \"pmids\": [\"22883624\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relationship between RTK signaling and the polarity scaffold function unclear\", \"Whether tyrosine phosphorylation modulates PAR binding not defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Broadened upstream inputs and outputs: Gαi1/3 are required for KGFR-to-GAB1 coupling, SFKs sustain spatially distal GAB1-SHP2 complexes selectively downstream of EGFR, SHP2 recruitment to GAB1 augments TGFβ-driven EMT, and GAB1 maintains hair follicle stem cell quiescence upstream of SHP2/MAPK.\",\n      \"evidence\": \"Co-IP, shRNA/siRNA, SFK inhibitors with computational modeling, SHP2 binding-dead rescue, conditional Gab1 knockout with Mek1(DD) rescue\",\n      \"pmids\": [\"25078664\", \"25969544\", \"26359300\", \"26456821\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of Gαi1/3-GAB1 coupling not structurally defined\", \"Why SFK-sustained complexes are EGFR-specific not fully explained\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified FER as an HGF-independent kinase that phosphorylates Met Y1349 to recruit GAB1 and selectively activate SHP2-ERK (not Akt), driving ovarian cancer invasion and metastasis.\",\n      \"evidence\": \"FER siRNA/shRNA, phosphosite antibodies, Co-IP, kinase assay, migration/invasion and in vivo metastasis models\",\n      \"pmids\": [\"27401557\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Basis for selective ERK (not Akt) activation by this route unexplained\", \"Generalizability beyond ovarian cancer untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Established a Mendelian disease link by showing a GAB1 PH-domain p.Gly116Glu mutation causes DFNB26 deafness, dysregulating HGF/MET/SHP2/SPRY2, with a METTL13 modifier forming a suppressive METTL13-GAB1-SPRY2 complex.\",\n      \"evidence\": \"Human genetic mapping, Co-IP of tripartite complex, zebrafish morpholino rescue, expression profiling in lymphoblastoid cells\",\n      \"pmids\": [\"29408807\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biochemical effect of G116E on PtdIns(3,4,5)P3 binding not directly measured\", \"Mechanism of METTL13 suppression not defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed GAB1 is an essential PDGF effector in oligodendrocyte precursors that binds GSK3β to regulate β-catenin-dependent myelination transcription factors, linking GAB1 to CNS myelination.\",\n      \"evidence\": \"Conditional Gab1 knockout in oligodendrocyte lineage, GSK3β Co-IP, β-catenin localization, transcription factor analysis, myelin staining\",\n      \"pmids\": [\"31944179\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How GAB1 regulates GSK3β activity mechanistically not resolved\", \"Whether GSK3β binding is direct or scaffold-mediated unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How GAB1's many context-specific effector modules (SHP2, PI3K, RasGAP, CRKL, Nck/N-WASP, Pak4, GSK3β, PAR proteins) are spatially and temporally selected by different upstream receptors to produce distinct cellular outputs remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No integrated structural/biophysical model of how phosphosite usage is selected per receptor\", \"Redundancy and division of labor between GAB1 and GAB2 not systematically mapped\", \"Quantitative rules governing positive vs negative feedback balance unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 12, 16, 44]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [5, 6]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [16, 31]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5, 6, 40]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [47, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [13, 16, 30]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [14, 37, 48, 51]}\n    ],\n    \"complexes\": [\n      \"GAB1-SHP2 complex\",\n      \"GAB1-PI3K(p85) complex\",\n      \"GAB1-SHP2-eNOS-PKA signalosome\",\n      \"METTL13-GAB1-SPRY2 complex\"\n    ],\n    \"partners\": [\n      \"MET\",\n      \"GRB2\",\n      \"PTPN11\",\n      \"PIK3R1\",\n      \"CRKL\",\n      \"SRC\",\n      \"CTTN\",\n      \"PAK4\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}